Document:

Tender and Voting Agreement

 Exhibit 10.1 
 EXECUTION COPY 
 TENDER AND VOTING AGREEMENT 

This TENDER AND VOTING AGREEMENT, dated as of July 11, 2011 (this “Agreement”), is among NCR Corporation, a
Maryland corporation (“Buyer”), Ranger Acquisition Corporation, a Georgia corporation and a wholly-owned subsidiary of Buyer (“Merger Sub”) and the persons listed on Schedule I hereto (collectively,
the “Company Shareholders”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Merger Agreement. 
 WHEREAS, as of the date hereof, each Company Shareholder is the record or “beneficial holder” (as defined under Rule 13d-3 under the Exchange Act) of the number of shares of common stock, no par
value (the “Company Common Stock”), of Radiant Systems, Inc., a Georgia corporation (the “Company”), set forth opposite such Company Shareholder’s name under the heading “Common Stock” on Schedule
I hereto (the “Existing Shares”) (the Existing Shares, together with any shares of Company Common Stock or any other class of equity securities of the Company acquired by a Company Shareholder after the date hereof, the
“Subject Shares”); provided that Company Options owned or beneficially owned by such Company Shareholder as of or after the date hereof (“Subject Options”) shall not be considered “Subject Shares”
prior to their exercise, and all shares of Company Common Stock issued upon exercise of Subject Options shall be considered “Subject Shares”); 
 WHEREAS, concurrently with the execution and delivery of this Agreement, Buyer, Merger Sub and the Company, are entering into an Agreement and Plan of Merger, dated as of the date hereof (as it may be
amended from time to time, the “Merger Agreement”; capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Merger Agreement), pursuant to which, among other things, (a) Merger
Sub will commence a tender offer to purchase all of the outstanding shares of Company Common Stock (such offer as it may be amended from time to time as permitted by the Merger Agreement, the “Offer”), and (b) following the
consummation of the Offer, Merger Sub will be merged with and into the Company (the “Merger”), with the Company being the surviving corporation, all upon the terms and subject to the conditions set forth in the Merger Agreement; and

 WHEREAS, as a condition to their willingness to enter into and perform its obligations under the Merger Agreement, Buyer and
Merger Sub have requested that each Company Shareholder enter into this Agreement, and each Company Shareholder has agreed to do so in order to induce Buyer and Merger Sub to commence the Offer and enter into the Merger Agreement; 

NOW, THEREFORE, in consideration of the foregoing and of the representations, warranties, covenants and agreements herein contained, and
intending to be legally bound hereby, the parties hereto agree as follows: 
 ARTICLE I 

AGREEMENT TO TENDER AND VOTE; IRREVOCABLE PROXY 
 Section 1.1 Agreement to Tender. 
 (a) Each
Company Shareholder agrees that as promptly as practicable after the commencement of the Offer, and in any event no later than the tenth (10th) Business Day following the commencement of the Offer, such Company Shareholder shall tender in the Offer all of
the Subject Shares owned by such Company Shareholder as of the date of such tender (with respect to each Company Shareholder his, her or its “Tender Date”), free and clear of all of all claims, liens, encumbrances and security
interests of any nature whatsoever that would prevent such Company Shareholder from tendering 

 
his shares in accordance with this Agreement or otherwise complying with his obligations under this Agreement. If any Company Shareholder acquires any Subject Shares after such Company
Shareholder’s Tender Date (including during any subsequent offering period, if any), such Company Shareholder shall tender into the Offer such Subject Shares within three Business Days following the date that such Company Shareholder shall
acquire such Subject Shares. 
 (b) Each Company Shareholder agrees that once the Subject Shares are tendered into the Offer,
such Company Shareholder shall not withdraw the tender of such Subject Shares unless the Offer shall have been terminated or shall have expired, in each case, in accordance with the terms of the Merger Agreement, or the Merger Agreement has been
terminated in accordance with its terms. 
 Section 1.2 Agreement to Vote. 

(a) From the date hereof until the termination of this Agreement in accordance with Section 5.1, except to the extent waived
in writing by Buyer in its sole and absolute discretion, at any special or annual meeting of the shareholders of the Company, however called, or at any adjournment thereof, or in connection with any written consent of the shareholders of the Company
or in any other circumstances upon which a vote, consent or other approval of all or some of the shareholders of the Company is sought, each Company Shareholder shall vote (or cause to be voted) all of such Company Shareholder’s Subject Shares
(to the extent the Subject Shares are not purchased in the Offer) and any other shares of capital stock of the Company owned, beneficially or of record, by such Company Shareholder during the term of this Agreement that are entitled to vote at such
meeting or in such written consent (collectively, the “Voting Shares”): (a) in favor of adoption and approval of the Merger Agreement and the transactions contemplated thereby, including but not limited to, the Merger; and
(b) against the following actions (other than the Merger and the transactions contemplated by the Merger Agreement): (i) any Acquisition Proposal; and (ii) any other action, transaction or proposal involving the Company or any of its
Subsidiaries that is intended or would reasonably be expected to result in any other conditions set forth in Article VIII of or Exhibit A to the Merger Agreement not being fulfilled or satisfied on or prior to the date of the Offer Closing or the
Expiration Date. 
 (b) In the event that a meeting of the shareholders of the Company is held, each Company Shareholder shall,
or shall cause the holder of record of its Voting Shares on any applicable record date to, appear at such meeting or otherwise cause its Voting Shares to be counted as present thereat for purposes of establishing a quorum. 

(c) Each Company Shareholder shall not enter into any agreement or understanding with any Person to vote or give instructions in any
manner inconsistent with the terms of this Section 1.2. 
 (d) EACH COMPANY SHAREHOLDER HEREBY IRREVOCABLY GRANTS TO
AND APPOINTS BUYER AND ANY DESIGNEE OF BUYER AND EACH OF BUYER’S OFFICERS, IN THEIR RESPECTIVE CAPACITIES AS OFFICERS OF BUYER, AND EACH OF THEM INDIVIDUALLY, SUCH COMPANY SHAREHOLDER’S PROXY AND ATTORNEY-IN-FACT (WITH FULL POWER OF
SUBSTITUTION), FOR AND IN THE NAME, PLACE AND STEAD OF SUCH COMPANY SHAREHOLDER, TO REPRESENT, VOTE AND OTHERWISE ACT (BY VOTING AT ANY MEETING OF SHAREHOLDERS OF THE COMPANY, BY WRITTEN CONSENT IN LIEU THEREOF OR OTHERWISE) WITH RESPECT TO THE
VOTING SHARES OWNED OR HELD BY SUCH COMPANY SHAREHOLDER REGARDING THE MATTERS REFERRED TO IN SECTION 1.2(a) HEREOF UNTIL THE TERMINATION OF THIS AGREEMENT, TO THE SAME EXTENT AND WITH THE SAME EFFECT AS SUCH COMPANY SHAREHOLDER MIGHT OR COULD
DO UNDER APPLICABLE LAW, RULES AND REGULATIONS. THE PROXY GRANTED PURSUANT TO THIS SECTION 1.2(d) IS COUPLED WITH AN INTEREST AND 

 
SHALL BE IRREVOCABLE. EACH COMPANY SHAREHOLDER WILL TAKE SUCH FURTHER ACTION AND WILL EXECUTE SUCH OTHER INSTRUMENTS AS MAY BE NECESSARY TO EFFECTUATE THE INTENT OF THIS PROXY. EACH COMPANY
SHAREHOLDER HEREBY REVOKES ANY AND ALL PREVIOUS PROXIES OR POWERS OF ATTORNEY GRANTED WITH RESPECT TO ANY OF THE VOTING SHARES THAT MAY HAVE HERETOFORE BEEN APPOINTED OR GRANTED WITH RESPECT TO THE MATTERS REFERRED TO IN SECTION 1.2(a)
HEREOF, AND NO SUBSEQUENT PROXY (WHETHER REVOCABLE OR IRREVOCABLE) OR POWER OF ATTORNEY SHALL BE GIVEN BY SUCH COMPANY SHAREHOLDER, EXCEPT AS REQUIRED BY ANY LETTER OF TRANSMITTAL IN CONNECTION WITH THE OFFER. THE PARTIES ACKNOWLEDGE AND AGREE THAT
NEITHER BUYER, NOR ANY OF ITS SUCCESSORS, ASSIGNS, AFFILIATES, SUBSIDIARIES, EMPLOYEES, OFFICERS, DIRECTORS, SHAREHOLDERS, AGENTS OR OTHER REPRESENTATIVES, SHALL INCUR ANY LIABILITY TO ANY SHAREHOLDER IN CONNECTION WITH OR AS A RESULT OF ANY
EXERCISE OF THE PROXY GRANTED TO BUYER PURSUANT TO THIS SECTION 1.2(d), OTHER THAN FOR A BREACH OF THIS SECTION 1.2(d). NOTWITHSTANDING THE FOREGOING, THIS PROXY SHALL TERMINATE UPON TERMINATION OF THIS AGREEMENT IN ACCORDANCE WITH ITS
TERMS. 
 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES OF EACH COMPANY SHAREHOLDER 
 Each
Company Shareholder hereby severally, and not jointly, represents and warrants to Buyer and Merger Sub (as to such Company Shareholder) as follows: 
 Section 2.1 Authority. Such Company Shareholder has all necessary legal capacity, power, and authority to execute and deliver this Agreement and to consummate the transactions contemplated by
this Agreement. Such Company Shareholder has duly executed and delivered this Agreement. Assuming the due authorization, execution, and delivery of this Agreement by Buyer, Merger Sub and each other Company Shareholder, this Agreement constitutes a
legal, valid, and binding obligation of such Company Shareholder, enforceable against such Company Shareholder in accordance with its terms. 
 Section 2.2 Ownership of Subject Shares; Total Shares. Such Company Shareholder is the record and beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of, and has good title to,
the Existing Shares listed beside such Company Shareholder’s name on Schedule I attached hereto, free and clear of all claims, liens, encumbrances and security interests of any nature whatsoever (including any restriction on the right to
vote or otherwise transfer such Existing Shares), except as set forth on Schedule I attached hereto, in the Company’s definitive proxy statement dated April 28, 2011 (the “Proxy Statement”) or provided hereunder or
pursuant to any applicable restrictions on transfer under the Securities Act. As of the date hereof, such Company Shareholder does not own, beneficially or otherwise, any Company Common Stock, Company Options or other securities of the Company other
than as set forth opposite such Company Shareholder’s name in Schedule I hereto. 
 Section 2.3 Voting
Power. Such Company Shareholder has sole voting power (and has not appointed or granted a proxy for such voting power) and sole power to issue instructions with respect to the matters set forth in this Agreement, sole power of disposition, sole
power of conversion, sole power to demand appraisal rights, and sole power to agree to all of the matters set forth in this Agreement, in each case with respect to all of such Company Shareholder’s Voting Shares, with no limitations,
qualifications, or restrictions on such rights, subject only to applicable securities laws and the terms of this Agreement. 

 Section 2.4 Consents and Approvals; No Violation. (i) Except as may be set
forth in the Merger Agreement and the Disclosure Letter issued by the Company in connection therewith (including, without limitation, filings as may be required under applicable securities laws) and any filing required under Section 13 or 16
under the Exchange Act, no filing with, and no permit, authorization, consent, or approval of, any Governmental Authority is necessary for the execution of this Agreement by such Company Shareholder and the consummation by such Company Shareholder
of the transactions contemplated by this Agreement, and (ii) none of the execution and delivery of this Agreement by such Company Shareholder, the consummation by such Company Shareholder of the transactions contemplated by this Agreement or
compliance by such Company Shareholder with any of the provisions of this Agreement shall (A) conflict with or result in any breach of the organizational documents, if applicable, of such Company Shareholder, (B) result in a material
violation or material breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions, or
provisions of any material note, bond, mortgage, indenture, license, contract, commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which such Company Shareholder is a party, or (C) subject to
compliance with filing requirements as may be required under applicable securities laws, violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to such Company Shareholder, except in each case under clauses
(A), (B) and (C), where the absence of filing or authorization, conflict, violation, breach, or default would not materially impair or adversely affect the ability of such Company Shareholder to perform such Company Shareholder’s
obligations hereunder. 
 Section 2.5 No Finder’s Fees. Except as contemplated by the Merger Agreement, no
broker, investment banker, financial advisor, or other person is entitled to any broker’s, finder’s, financial advisor’s, or other similar fee or commission in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of such Company Shareholder in such Company Shareholder’s individual capacity. 

Section 2.6 Acknowledgement. Such Company Shareholder understands and acknowledges that each of Buyer and Merger Sub is
entering into the Merger Agreement in reliance upon such Company Shareholder’s execution, delivery and performance of this Agreement. 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

 Buyer and Merger Sub hereby represent and warrant to the Company Shareholders as follows: 

Section 3.1 Organization. Each of Buyer and Merger Sub is a corporation duly organized, validly existing, and in good
standing under the laws of the jurisdiction of its incorporation. 
 Section 3.2 Corporate Authorization; Validity of
Agreement; Necessary Action. Buyer and Merger Sub have the corporate power and authority to execute and deliver this Agreement and to consummate the transactions contemplated by this Agreement. The execution and delivery of this Agreement by
Buyer and Merger Sub and the consummation of the transactions contemplated by this Agreement have been duly authorized by all necessary action on the part of Buyer and Merger Sub, and, assuming the due authorization, execution and delivery thereof
by the Company and each of the Company Shareholders, this Agreement constitutes a valid and legally binding agreement of Buyer and Merger Sub enforceable against each of them in accordance with its terms. 

 Section 3.3 Consents and Approvals; No Violation. (i) Except as may be set
forth in the Merger Agreement (including, without limitation, filings as may be required under applicable securities laws) and any filing required under Section 13 or 16 under the Exchange Act, no filing with, and no permit, authorization,
consent, or approval of, any Governmental Authority is necessary for the execution of this Agreement by each of Buyer and Merger Sub and the consummation by each of Buyer and Merger Sub of the transactions contemplated by this Agreement, and
(ii) none of the execution and delivery of this Agreement by each of Buyer and Merger Sub, the consummation by each of Buyer and Merger Sub of the transactions contemplated by this Agreement or compliance by each of Buyer and Merger Sub with
any of the provisions of this Agreement shall (A) conflict with or result in any breach of the organizational documents Buyer or Merger Sub, (B) result in a material violation or material breach of, or constitute (with or without notice or
lapse of time, or both) a default (or give rise to any third party right of termination, cancellation, amendment, or acceleration) under any of the terms, conditions, or provisions of any material note, bond, mortgage, indenture, license, contract,
commitment, arrangement, understanding, agreement, or other instrument or obligation of any kind to which Buyer or Merger Sub is a party, or (C) subject to compliance with filing requirements as may be required under applicable securities laws,
violate any order, writ, injunction, decree, judgment, statute, rule, or regulation applicable to Buyer or Merger Sub, except in each case under clauses (A), (B) or (C), where the absence of filing or authorization, conflict, violation, breach,
or default would not materially impair or adversely effect the ability of each of Buyer and Merger Sub to perform its obligations hereunder. 
 ARTICLE IV 
 COVENANTS OF EACH COMPANY SHAREHOLDER 

Each Company Shareholder severally covenants and agrees as follows: 

Section 4.1 Restriction on Transfer, Proxies, and Non-Interference. Except as contemplated by this Agreement or the Merger
Agreement or as required by applicable law, during the period beginning from the execution and delivery by the parties of this Agreement through the earlier of the termination of this Agreement in accordance with Section 5.1, each
Company Shareholder shall not (i) directly or indirectly, offer for sale or redemption, sell, transfer, tender, pledge, encumber, assign, or otherwise dispose of (each, a “Transfer”), or enter into any Contract with respect to
the Transfer of, any or all of such Company Shareholder’s Subject Shares, Subject Options or any other securities of the Company or to any Person, other than pursuant to the Merger Agreement or the Offer or in connection with the exercise of
any Subject Options (it being understood and agreed that any shares of Company Common Stock issued upon the exercise of Subject Options or deemed issued upon the vesting of any Common Stock Unit or Company Restricted Shares shall be subject to the
restrictions set forth in this Section 4.1); (ii) grant any proxies or powers of attorney, or any other authorization or consent with respect to any or all of such Company Shareholder’s Subject Shares; (iii) deposit any of such
Shareholder’s Subject Shares or Subject Options into a voting trust or enter into a voting agreement with respect to any of such Company Shareholder’s Subject Shares or Subject Options, other than pursuant to this Agreement or
(iv) take any action that would make any representation or warranty of such Company Shareholder contained in this Agreement to be untrue or incorrect in any material respect (other than as a result of the Transfer of any Subject Shares or
Subject Options pursuant to the Merger Agreement or the Offer) if made by such Company Shareholder as of any date in which this Agreement is in effect or that would reasonably be expected to have the effect of preventing or disabling or delaying
such Company Shareholder from performing such Company Shareholder’s obligations under this Agreement; provided, however, that the actions described in Sections 4.1(i) and (iii) shall be permitted to the extent such action is the result of
a donative transfer to any immediate family member of the Company Stockholder or a charitable organization or a trust for the benefit of such Company Stockholder; immediate family member or charitable organization and such transferee agrees in
writing to be bound by the terms hereof. 

 Section 4.2 Stop Transfer; Changes in Subject Shares. Each Company Shareholder
agrees with, and covenants to, Buyer and Merger Sub that (i) this Agreement and the obligations hereunder shall attach to such Company Shareholder’s Subject Shares and Subject Options and shall be binding upon any person or entity to which
legal or beneficial ownership shall pass, whether by operation of law or otherwise, including, without limitation, such Company Shareholder’s successors or assigns and (ii) such Company Shareholder shall not request that the Company
register the transfer (book-entry or otherwise) of any certificate or uncertificated interest representing any or all of the Company Shareholder’s Subject Shares or Subject Options, unless such transfer is made in compliance with this
Agreement. Notwithstanding any Transfer of Subject Shares or Subject Options, the transferor shall remain liable for the performance of all of the obligations of the applicable Company Shareholder under this Agreement, except for any such Transfer
pursuant to the Merger Agreement or the Offer. 
 Section 4.3 Appraisal Rights. Each Company Shareholder hereby
waives any rights of appraisal or rights to dissent from the Merger that such Company Shareholder may have (including, without limitation, under Sections 14-2-1301 et. seq. of the GBCC). 

Section 4.4 Additional Securities. In the event any Company Shareholder becomes the record or beneficial owner of
(i) any shares of Company Common Stock or any other securities of the Company, (ii) any securities which may be converted into or exchanged for such shares or other securities of the Company or (iii) any securities issued in
replacement of, or as a dividend or distribution on, or otherwise in respect of, such shares or other securities of the Company (collectively, “Additional Securities”), the terms of this Agreement shall apply to any of such
Additional Securities as though owned by such Company Shareholder on the date of this Agreement. 
 Section 4.5
Shareholder and Optionholder Capacity. Each Company Shareholder enters into this Agreement solely in its capacity as the record or beneficial owner of its Subject Shares and Subject Options. Nothing contained in this Agreement shall limit the
rights and obligations of any Company Shareholder, any of its Affiliates, Representatives or any employee of any of its Affiliates in his or her capacity as a director or officer of the Company, and the agreements set forth herein shall in no way
restrict any director or officer of the Company in the exercise of his or her fiduciary duties as a director or officer of the Company. 
 Section 4.6 Documentation and Information. Each Company Shareholder (i) consents to and authorizes the publication and disclosure by Buyer and its affiliates of its identity and holding
of such Company Shareholder’s Subject Shares and Subject Options and the nature of its commitments and obligations under this Agreement in any announcement or disclosure required by the SEC or other Governmental Authority, the Offer Documents,
or any other disclosure document in connection with the Offer, the Merger or any of the other transactions contemplated by the Merger Agreement or this Agreement, and (ii) agrees promptly to give to Buyer any information it may reasonably
require for the preparation of any such disclosure documents. Each Company Shareholder agrees to promptly notify Buyer of any required corrections with respect to any written information supplied by it specifically for use in any such disclosure
document, if and to the extent that any shall have become false or misleading in any material respect. 
 Section 4.7 No
Solicitation. During the term of this Agreement, each Company Shareholder agrees that it shall not (whether directly or indirectly through its advisors, agents or other intermediaries), engage in any conduct as to which the Company is prohibited
by Section 6.2 of the Merger Agreement; provided, however, that nothing herein shall prevent Company Stockholder from acting in his or her capacity as an employee, officer or director of the Company, or taking any action in such capacity
(including at the direction of the Company Board), but only in either such case as and to the extent permitted by Section 6.2 of the Merger Agreement. 

 ARTICLE V 
 TERMINATION 
 Section 5.1 This Agreement and the covenants and
agreements set forth in this Agreement shall terminate automatically (without any further action of the parties) upon the earlier to occur of (i) the termination of the Merger Agreement in accordance with its terms, (ii) the termination or
expiration of the Offer, without any Subject Shares being accepted for payment thereunder, (iii) the effective time of the Merger contemplated by the Merger Agreement and (iv) the amendment of the terms of the Offer to reduce the price or
change the form of consideration to be paid for the Company Common Stock. In the event of termination of this Agreement pursuant to this Section 5.1, this Agreement shall become void and of no effect with no liability on the part of any
party; provided, however, no such termination shall relieve any party from liability for any breach hereof prior to such termination, and this Section 5.1 and Article VI shall survive any such termination. 

ARTICLE VI 

MISCELLANEOUS 
 Section 6.1 Governing Law; Jurisdiction; Waiver of Jury Trial. 
 (a)
This Agreement shall be governed by and construed in accordance with the laws of the State of Georgia, regardless of the laws that might otherwise govern under applicable principles of conflicts of law thereof. 

(b) Each of the parties hereto (i) irrevocably consents to the service of the summons and complaint and any other process in any
action or proceeding relating to the transactions contemplated by this Agreement, for and on behalf of itself or any of its properties or assets, in accordance with Section 6.5 or in such other manner as may be permitted by applicable
Law, and nothing in this Section 6.1(b) shall affect the right of any party to serve legal process in any other manner permitted by applicable Law; (ii) irrevocably and unconditionally consents and submits itself and its properties
and assets in any action or proceeding to the exclusive jurisdiction of the Business Courts of the Superior Court of Fulton County, Georgia (and if jurisdiction in such courts shall be unavailable, the United States District Court for the Northern
District of Georgia) in the event any dispute or controversy arises out of this Agreement or the transactions contemplated hereby, or for recognition and enforcement of any judgment in respect thereof; (iii) agrees that it will not attempt to
deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (iv) agrees that any actions or proceedings arising in connection with this Agreement or the transactions contemplated hereby shall be brought,
tried and determined only in the Business Courts of the Superior Court of Fulton County, Georgia (and if jurisdiction in such courts shall be unavailable, the United States District Court for the Northern District of Georgia); (v) waives any
objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same; and (vi) agrees that
it will not bring any action relating to this Agreement or the transactions contemplated hereby in any court other than the aforesaid courts. Each of Buyer, Merger Sub and the Company Shareholders agrees that a final judgment in any action or
proceeding in such courts as provided above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable law. 

(c) EACH OF PARENT, MERGER SUB AND THE COMPANY SHAREHOLDERS HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR 

 
OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF PARENT, MERGER SUB OR THE COMPANY SHAREHOLDERS IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF.

 Section 6.2 Specific Performance. Each Company Shareholder acknowledges and agrees that (a) the covenants,
obligations and agreements of such Company Shareholder contained in this Agreement relate to special, unique and extraordinary matters, (b) Buyer is and will be relying on such covenants, obligations and agreements in connection with entering
into the Merger Agreement and the performance of Buyer’s obligations under the Merger Agreement, and (c) a violation of any of the covenants, obligations or agreements of such Company Shareholder contained in this Agreement will cause
Buyer irreparable injury for which adequate remedies are not available at law. Therefore, each Company Shareholder agrees that Buyer shall be entitled to an injunction, restraining order or such other equitable relief (without the requirement to
post bond) as a court of competent jurisdiction may deem necessary or appropriate to restrain such Company Shareholder, as the case may be, from committing any violation of such covenants, obligations or agreements and to specifically enforce the
terms of this Agreement. These injunctive remedies are cumulative and in addition to any other rights and remedies Buyer may have under applicable law. 
 Section 6.3 Assignment; No Third Party Beneficiaries. This Agreement shall not be assignable or otherwise transferable by a party without the prior consent of the other parties, and any
attempt to so assign or otherwise transfer this Agreement without such consent shall be void and of no effect; provided, however, that Buyer may, in its sole discretion, assign or transfer all or any of its rights, interests and
obligations under this Agreement to any direct or indirect wholly owned subsidiary of Buyer, but no such assignment shall relieve Buyer from its obligations under this Agreement. This Agreement shall be binding upon the respective heirs, successors,
legal representatives and permitted assigns of the parties hereto. Nothing in this Agreement shall be construed as giving any Person, other than the parties hereto and their heirs, successors, legal representatives and permitted assigns, any right,
remedy or claim under or in respect of this Agreement or any provision hereof. 
 Section 6.4 Amendments, Waivers,
etc. Neither this Agreement nor any term hereof may be amended other than by an instrument in writing signed by Buyer, Merger Sub and the Company Shareholders. No provision of this Agreement may be waived, discharged or terminated other than by
an instrument in writing signed by the party against whom the enforcement of such waiver, discharge or termination is sought, except that this Agreement may be terminated as set forth in Section 5.1. 

Section 6.5 Notices. All notices, requests and other communications to any party hereunder shall be in writing and shall be
deemed given if delivered either personally, by facsimile transmission (with acknowledgment received), by electronic mail (with receipt confirmed) or by overnight courier (providing proof of delivery) to the parties at the following addresses:

 If to the Company Shareholders: At the address set forth beside each Company Shareholder’s name listed on Schedule
I. 
 If to Buyer or Merger Sub, to: 
 NCR Corporation 
 3097 Satellite Boulevard 
 Duluth, Georgia 30096 
 Fax: (866) 680-1059 

Attention: General Counsel/Notices, 2nd Floor 

 with a copy to: 
 Womble Carlyle Sandridge Rice, PLLC 
 271 17th Street NW, Suite 2400 

Atlanta, Georgia 30363 

			
	Fax:	  	(404) 870-4825
	Attn:	  	Sharon McBrayer Johnson

 or such other address, facsimile number or email address as such party may hereafter specify by notice to the other
parties hereto. All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5 P.M. in the place of receipt and such day is a Business Day in the place of receipt.
Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt. 
 Section 6.6 Expenses. Except as otherwise provided herein, all costs and expenses incurred in connection with the transactions contemplated by this Agreement shall be paid by the party
incurring such costs and expenses. 
 Section 6.7 Remedies. No failure or delay by any party in exercising any
right, power or privilege under this Agreement shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and
remedies provided herein shall be cumulative and not exclusive of any rights or remedies provided by law. 
 Section 6.8
Severability. If any term or provision of this Agreement is held to be invalid, illegal, incapable of being enforced by any rule of law, or public policy, or unenforceable for any reason, it shall be adjusted rather than voided, if possible,
in order to achieve the intent of the parties hereto to the maximum extent possible. In any event, the invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall not affect the validity or enforceability of the
remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision, in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of
being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the terms of this Agreement remain as
originally contemplated to the fullest extent possible. 
 Section 6.9 Entire Agreement. This Agreement constitutes
the entire agreement among the parties with respect to the subject matter of this Agreement and supersedes all other prior agreements and understandings, both written and oral, between the parties with respect to the subject matter of this
Agreement. 
 Section 6.10 Further Assurances. From time to time at the request of Buyer, and without further
consideration, each Company Shareholder shall execute and deliver or cause to be executed and delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to effect the matters
contemplated by this Agreement. 
 Section 6.11 Section Headings. The article and section headings used in this
Agreement are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. 
 Section 6.12 Public Announcements. No Company Shareholder shall issue any press release or make any other public statement with respect to the transactions contemplated by this Agreement and

 
the Merger Agreement without the prior written consent of Buyer, except as such release or statement may be required by applicable Law or the rules and regulations of any applicable United States
securities exchange or regulatory or Governmental Authority to which the relevant Company Shareholder is subject or submits. 

Section 6.13 Counterparts. This Agreement may be executed in two or more counterparts, each of which when executed shall be
deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier shall be effective as delivery of a manually executed
counterpart of this Agreement. 
 [SIGNATURE PAGES FOLLOW] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

			
	NCR CORPORATION
		
	By:	 	 /s/ William Nuti

	Name:	 	William Nuti
	Title:	 	Chairman of the Board, Chief Executive Officer, President
	
	RANGER ACQUISITION CORPORATION
		
	By:	 	 /s/ John G. Bruno

	Name:	 	John G. Bruno
	Title:	 	Chief Executive Officer and President

 [Signature Page to Tender and Voting Agreement] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Alon Goren

		 		 	Print Name of Individual
			
		 		 	 /s/ Alon Goren

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 John H. Heyman

		 		 	Print Name of Individual
			
		 		 	 /s/ John H. Heyman

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Andrew S. Heyman

		 		 	Print Name of Individual
			
		 		 	 /s/ Andrew S. Heyman

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Mark E. Haidet

		 		 	Print Name of Individual
			
		 		 	 /s/ Mark E. Haidet

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Carlyle Taylor

		 		 	Print Name of Individual
			
		 		 	 /s/ Carlyle Taylor

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 James S. Balloun

		 		 	Print Name of Individual
			
		 		 	 /s/ James S. Balloun

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 William A. Clement, Jr.

		 		 	Print Name of Individual
			
		 		 	 /s/ William A. Clement, Jr.

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 J. Alexander M. Douglas, Jr.

		 		 	Print Name of Individual
			
		 		 	 /s/ J. Alexander M. Douglas, Jr.

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Philip J. Hickey, Jr.

		 		 	Print Name of Individual
			
		 		 	 /s/ Philip J. Hickey, Jr.

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Donna A. Lee

		 		 	Print Name of Individual
			
		 		 	 /s/ Donna A. Lee

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

							
	Signature by Individual:	 		 	 Nick Shreiber

		 		 	Print Name of Individual
			
		 		 	 /s/ Nick Shreiber

		 		 	Signature of Individual
			
	Signature by Additional Individual as Co-Owner
(jointly or in common):	 		 	  

		 		 	Print Name of Individual Co-Owner
			
		 		 	  

		 		 	Signature of Individual Co-Owner
			
		 		 	as (check one):
		 		 	       ̈ tenants in common; or
		 		 	       ̈ JTWROS
			
	Signature by Entity:	 		 	  

		 		 	Print Name of Partnership, Company, Trust or Other Entity
			
		 		 	  

		 		 	State of Formation of Entity
				
		 		 	By:	 	  

		 		 		 	Signature of Authorized Agent
				
		 		 		 	  

		 		 		 	Print Name of Authorized Agent
				
		 		 	Title:	 	  

 [Signature Page to Tender and Voting Agreement Continued] 

 Schedule I 

Company Shareholders 
  

					
	 Company Shareholder
	  	 Company Common Stock1
	  	 Subject Options

			
	 Alon Goren

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	2,912,792 shares	  	148,675 options
			
	 John H. Heyman

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	384,373 shares	  	296,875 options
			
	 Andrew S. Heyman

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	321,236 shares	  	288,401 options
			
	 Mark E. Haidet

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	76,476 shares	  	72,578 options
			
	 Carlyle Taylor

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	88,589 shares	  	62,778 options
			
	 James S. Balloun

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	94,372 shares	  	84,483 options
			
	 William A. Clement, Jr.

5726 Registry Oaks Lane SE

Mableton, GA 30126
	  	52,083 shares	  	52,083 options
			
	 J. Alexander M. Douglas, Jr.

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	108,382 shares	  	89,483 options

					
	 Company Shareholder
	  	 Company Common Stock1
	  	 Subject Options

			
	 Philip J. Hickey, Jr.

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	0 shares	  	0 options
			
	 Donna A. Lee

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	51,083 shares	  	51,083 options
			
	 Nick Shreiber

c/o Radiant Systems, Inc.

3925 Brookside Parkway

Alpharetta, GA 30022
	  	0 shares	  	0 options

 1 Alon Goren 150,000 shares are subject to pledge in connection with ownership of property.Exhibit 4.1

 Exhibit 4.1 
 GENERAL DYNAMICS CORPORATION 
 Debt Securities 

UNDERWRITING AGREEMENT 
 July 5, 2011 
 To the Representatives named in 

Schedule I hereto of the 
 Underwriters named in

 Schedule II hereto 
 Ladies and
Gentlemen: 
 1. Introduction. General Dynamics Corporation, a Delaware corporation (the “Company”),
proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as representatives (the
“Representatives”), the principal amount of its debt securities identified in Schedule I hereto (the “Notes”), to be unconditionally guaranteed by the subsidiaries of the Company identified on Schedule IV hereto
(collectively, the “Guarantors” and, together with the Company, the “Issuers”). The Securities will be issued pursuant to the indenture dated as of August 27, 2001, by and among the Company, the Guarantors
thereunder and The Bank of New York Mellon (formerly The Bank of New York), as trustee (the “Indenture”). The obligations of the Company under the Indenture and the Notes will be unconditionally guaranteed (the
“Guarantees” and together with the Notes, the “Securities”), on a joint and several basis, by each of the Guarantors in accordance with the terms of the Indenture. 

The Issuers have prepared and filed with the Securities and Exchange Commission (the “Commission”) under the Securities
Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”) a registration statement on Form S-3 (File No. 333-155980), including a prospectus (the “Basic
Prospectus”), relating to debt securities and guarantees thereof to be issued from time to time by the Issuers. The Issuers have also filed with, or transmitted for filing to, or shall promptly hereafter file with or transmit for filing to,
the Commission a prospectus supplement specifically relating to the Securities pursuant to Rule 424 under the Securities Act (the “Prospectus Supplement”). The term “Registration Statement” means the registration
statement, as amended at the time it becomes effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (“Rule
430 Information”). The term “Prospectus” means the Basic 

 
Prospectus as supplemented by the prospectus supplement specifically relating to the Securities in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the
Securities Act) in connection with confirmation of sales of the Securities. The term “Preliminary Prospectus” means the preliminary prospectus supplement specifically relating to the Securities together with the Basic Prospectus. As
used herein, the terms “Basic Prospectus,” “Prospectus” and “Preliminary Prospectus” shall include in each case the documents, if any, incorporated by reference therein. The terms “supplement,”
“amendment” and “amend” as used herein with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed by the Company under the Securities and
Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (the “Exchange Act”) subsequent to the date of the Underwriting Agreement which are deemed to be incorporated by reference therein. For
purposes of this Agreement, the term “Effective Time” means the effective date of the Registration Statement with respect to the offering of Securities, as determined for the Company pursuant to Section 11 of the Securities Act
and Item 512 of Regulation S-K, as applicable. 
 At or prior to the time when sales of the Securities will be first made
(the “Time of Sale”), the Company will prepare certain information (collectively, the “Time of Sale Information”) which information will be identified in Schedule III to the Underwriting Agreement for such offering
of Securities as constituting part of the Time of Sale Information. 
 The Issuers hereby agree with the Underwriters as
follows: 
 2. Representations and Warranties of the Issuers. 

(a) The Company represents and warrants to and agrees with each of the Underwriters that: 

(i) The Registration Statement is an “automatic shelf registration statement” as defined under Rule 405 of
the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission and no proceeding for that purpose or pursuant to Section 8A of
the Securities Act against the Company or related to the offering has been initiated or threatened by the Commission; as of the Effective Time, the Registration Statement complied in all material respects with the Securities Act

  
 2 

 
and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Trust Indenture Act”), and did not or will not
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement
thereto and as of the Closing Date, the Prospectus complied in all material respects with the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation and warranty with respect to (i) that part of the
Registration Statement that constitutes the Statement of Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii) any statements or omissions in the Registration Statement and the Prospectus and any
amendment or supplement thereto made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein. 

(ii) The Time of Sale Information, at the Time of Sale and at the Closing Date did not and will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation and
warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such
Time of Sale Information. 
 (iii) The Issuers (including their agents and representatives, other than the
Underwriters in their capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any “written communication” (as defined in Rule 405 under the
Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication referred to in clauses (i), (ii) and
(iii) below) an “Issuer Free Writing Prospectus”) other than (i) any 

  
 3 

 
document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act, (ii) the Preliminary Prospectus, (iii) the
Prospectus, (iv) the documents, other than the Preliminary Prospectus, listed on Schedule III to the Underwriting Agreement as constituting part of the Time of Sale Information and (v) any electronic road show or other written
communications, in each case approved in writing in advance by the Representatives. Each Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433)
filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, or filed prior to the first use of such Issuer Free Writing
Prospectus, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; provided that the Company makes no representation and warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Issuer Free Writing Prospectus. 
 (iv) The documents incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Information when filed with the Commission, conformed or will conform, as the case may be,
in all material respects with the requirements of the Exchange Act, and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; 
 (v) The Securities have
been duly authorized by the Company; the Guarantees have been duly authorized by the applicable Guarantors; and when the Securities are delivered and paid for pursuant to this Agreement on the Closing Date (as defined below) assuming due
authentication by the trustee under the Indenture, such Securities will have been duly executed, issued and delivered by the Issuers and will conform in all material respects to the description thereof contained in the Registration Statement, the
Time of Sale Information and the 

  
 4 

 
Prospectus and the provisions of the Indenture and will constitute valid and legally binding obligations of the Issuers, in each case enforceable in accordance with their respective terms,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles. 

(vi) Since the date as of which information is given in the Registration Statement, the Time of Sale Information and the
Prospectus, (a) there has not been any material adverse change, or any development reasonably likely to have a material adverse change, in the condition (financial or otherwise), financial position, stockholders’ equity or results of
operations of the Company and its subsidiaries, considered as one enterprise, whether or not arising in the ordinary course of business, and (b) there have been no transactions entered into by the Company or any of its subsidiaries which,
individually or in the aggregate, are material to the Company and its subsidiaries, considered as one enterprise, other than those transactions in the ordinary course of business, except, in each case, as otherwise set forth or contemplated in the
Registration Statement, the Time of Sale Information and the Prospectus. 
 (vii) The Company has been duly
incorporated and is validly existing as a corporation in good standing under the laws of its jurisdiction of incorporation, with power and authority (corporate and other) to own its properties and conduct its business as described in the
Registration Statement, the Time of Sale Information and the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or
leases properties or conducts any business so as to require such qualification, except where the failure to be so qualified is not reasonably likely to have a material adverse change in the condition (financial or otherwise), financial position,
stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise. 
 (viii) Each Guarantor has been duly incorporated and is validly existing as a corporation in good standing under the laws of its jurisdiction of incorporation, with power and authority (corporate and
other) to own its properties and conduct its business as described in the Registration Statement, the Time of Sale Information and the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in

  
 5 

 
good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except where the failure to be so
qualified is not reasonably likely to have a material adverse change in the condition (financial or otherwise), financial position, or results of operations of the applicable Guarantor and its subsidiaries, considered as one enterprise. 

(ix) The Company has an authorized capitalization as set forth in the Registration Statement, the Time of Sale Information
and the Prospectus, and all of the issued shares of capital stock of the Company have been duly and validly authorized and issued, are fully paid and non-assessable; and all of the issued shares of capital stock of each Guarantor have been duly and
validly authorized and issued, are fully paid and non-assessable and (except for directors’ qualifying shares) are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. 

(x) The execution, delivery and performance of the Indenture and this Agreement and the issuance and sale of the
Securities and the compliance by the Company with all of the provisions thereof and the consummation by the Company of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions
of, or constitute a default under, any material indenture, mortgage, deed of trust, loan agreement or other material agreement or instrument to which the Company is a party or by which the Company is bound or to which any of the property or assets
of the Company is subject, nor will such actions result in any violation of the provisions of the Certificate of Incorporation or By-laws of the Company or, to the best of its knowledge, any statute or any order, rule or regulation of any court or
governmental agency or body having jurisdiction over the Company or any of its properties; and no consent, approval, authorization, order, decree, registration or qualification of or with any such court or governmental agency or body is required for
the issuance and sale of the Securities or the consummation by the Company of the transactions contemplated by this Agreement, except such consents, approvals, authorizations, registrations or qualifications as may be required under state or foreign
securities or “blue sky” laws or as have been obtained under the Securities Act or the Trust Indenture Act in connection with the issuance and sale of the Securities by the Issuers; and each of the Issuers has full power and authority to
authorize, issue and sell the Securities as contemplated by this Agreement. 

  
 6 

 (xi) The execution, delivery and performance of the Indenture and this
Agreement and the issuance and sale of the Securities and the compliance by each of the Guarantors with all of the provisions thereof and the consummation by each of the Guarantors of the transactions contemplated herein will not conflict with or
result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which any of the Guarantors are a party or by which any
of the Guarantors are bound or to which any of the property or assets of any of the Guarantors are subject, except where such conflict, breach, violation or default is not reasonably likely to result in a material adverse change in the condition
(financial or otherwise), financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise, nor will such actions result in any violation of the provisions of the Certificate of
Incorporation or By-laws of any of the Guarantors or, to the best of the Company’s knowledge, any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Guarantors or any of their
respective properties; and no consent, approval, authorization, order, decree, registration or qualification of or with any such court or governmental agency or body is required for the issuance of any of the Guarantees or the consummation by any of
the Guarantors of the transactions contemplated by this Agreement, except such consents, approvals, authorizations, registrations or qualifications as may be required under state or foreign securities or “blue sky” laws or as have been
obtained under the Securities Act or the Trust Indenture Act in connection with the issuance of the Guarantees. 

(xii) This Agreement has been duly authorized, executed and delivered by each of the Issuers. 

(xiii) The Indenture has been duly qualified under the Trust Indenture Act and has been duly authorized, executed and
delivered by each of the Issuers and is a valid and legally binding obligation of the Issuers, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors’ rights and to general equity principles. 

  
 7 

 (xiv) None of the Issuers is i) in violation of its Certificate of
Incorporation or By-laws or ii) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it
is a party or by which it or any of its properties may be bound, where such default is reasonably likely to result in a material adverse change in the condition (financial or otherwise), financial position, stockholders’ equity or results of
operations of the Company and its subsidiaries, considered as one enterprise. 
 (xv) Other than as set forth in
the Registration Statement, the Time of Sale Information and the Prospectus, there are no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its
subsidiaries is the subject which is reasonably likely by the Company to have, individually or in the aggregate, a material adverse change in the condition (financial or otherwise), financial position, stockholders’ equity or results of
operations of the Company and its subsidiaries, considered as one enterprise; and, to the best of the Company’s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened by others. 

(xvi) The Company is not and, after giving effect to the offering and sale of the Securities, will not be an
“investment company,” as such term is defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”). 
 (xvii) The financial statements included or incorporated by reference in the Registration Statement, the Time of Sale Information and Prospectus present fairly, in all material respects, the
financial position of the Company and its consolidated subsidiaries as of the dates shown and their results of operations and cash flows for the periods shown, and, except as otherwise disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, such financial statements have been prepared in conformity with accounting principles generally accepted in the United States; any schedules included in the Registration Statement, the Time of Sale Information and the
Prospectus present fairly, in all material respects, the information required to be stated therein. 

  
 8 

 (xviii) Except as disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, since the date of the latest audited financial statements included in the Registration Statement, the Time of Sale Information and the Prospectus, there has been no material adverse change, nor any development
reasonably likely to have a material adverse change, in the condition (financial or otherwise), financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise. 

(xix) KPMG LLP, who has certified certain financial statements of the Company and its subsidiaries, is, to the best of the
Company’s knowledge, an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board
(United States) and as required by the Securities Act. 
 (xx) The Company is not an “ineligible
issuer” and is a “well-known seasoned issuer”, in each case as defined under the Securities Act, in each case at the times specified in the Securities Act in connection with the offering of the Securities. 

(xxi) The Company and its subsidiaries maintain an effective system of “disclosure controls and procedures” (as
defined in Rule 13a-15(e) of the Exchange Act) and have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act. 

(xxii) The Company and its subsidiaries maintain systems of “internal control over financial reporting” (as
defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act. Except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, there are no material weaknesses in the
Company’s internal controls. 
 (b) Each Guarantor, severally, and not jointly, represents and warrants to
and agrees with the Underwriters that: 
 (i) The Registration Statement is an “automatic shelf
registration statement” as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration
statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order 

  
 9 

 
suspending the effectiveness of the Registration Statement has been issued by the Commission and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the
Company or related to the offering has been initiated or threatened by the Commission; as of the Effective Time, the Registration Statement complied in all material respects with the Securities Act and the Trust Indenture Act, and did not or will
not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or
supplement thereto and as of the Closing Date, the Prospectus did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided that such Guarantor makes no representation and warranty with respect to (i) that part of the Registration Statement that constitutes the Statement of
Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii) any statements or omissions in the Registration Statement and the Prospectus and any amendment or supplement thereto made in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein. 

(ii) The Time of Sale Information, at the Time of Sale and at the Closing Date did not and will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the applicable Guarantor makes no
representation and warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the applicable Guarantor in writing by such Underwriter through the
Representatives expressly for use in such Time of Sale Information. 
 (iii) Each Guarantor (including its agents
and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any “written communication” (as
defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities other than (i) any 

  
 10 

 
document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act, (ii) the Preliminary Prospectus, (iii) the
Prospectus, (iv) the documents, other than the Preliminary Prospectus, listed on Schedule III to the Underwriting Agreement as constituting the Time of Sale Information and (v) any electronic road show or other written communications, in
each case approved in writing in advance by the Representatives. Each Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance
with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, or filed prior to the first use of such Issuer Free Writing Prospectus, did not, and
at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
provided that such Guarantor makes no representation and warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Issuer Free Writing Prospectus. 
 (iv) The applicable Guarantee has been duly authorized by the Guarantor; and when such Guarantee is delivered pursuant to this Agreement on the Closing Date, such Guarantee will have been duly executed,
issued and delivered and will conform in all material respects to the description thereof contained in the Registration Statement, the Time of Sale Information and the Prospectus and the provisions of the Indenture and will constitute a valid and
legally binding obligation of the Guarantor, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting
creditors’ rights and to general equity principles. 
 (v) The Guarantor has been duly incorporated and is
validly existing as a corporation in good standing under the laws of its jurisdiction of incorporation, with power and authority (corporate and other) to own its properties and conduct its business as described in the Registration Statement, the
Time of Sale Information and the Prospectus, and has been duly qualified 

  
 11 

 
as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to
require such qualification, except where the failure to be so qualified is not reasonably likely to have a material adverse change, in the condition (financial or otherwise), financial position or results of operations of the Guarantor and its
subsidiaries, considered as one enterprise. 
 (vi) The execution, delivery and performance of the Indenture and
this Agreement and the issuance of the applicable Guarantee and the compliance by the Guarantor with all of the provisions thereof and the consummation by the Guarantor of the transactions contemplated herein will not conflict with or result in a
breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Guarantor is a party or by which the Guarantor is bound or
to which any of the property or assets of the Guarantor is subject, except where such conflict, breach, violation or default is not reasonably likely to result in a material adverse change in the condition (financial or otherwise), financial
position, stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise, nor will such action result in any violation of the provisions of the Certificate of Incorporation or By-laws of the
Guarantor or, to the best of its knowledge, any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Guarantor or any of its properties; and no consent, approval, authorization, order,
decree, registration or qualification of or with any such court or governmental agency or body is required for the issuance of the applicable Guarantee or the consummation by the Guarantor of the transactions contemplated by this Agreement, except
such consents, approvals, authorizations, registrations or qualifications as may be required under state or foreign securities or “blue sky” laws or as have been obtained under the Securities Act or the Trust Indenture Act in connection
with the issuance and sale of the Securities by the Issuers; and the Guarantor has full power and authority to authorize and issue the Guarantee as contemplated by this Agreement. 

(vii) This Agreement has been duly authorized, executed and delivered by the Guarantor. 

  
 12 

 (viii) The Indenture has been duly qualified under the Trust Indenture Act
and has been duly authorized, executed and delivered by the Guarantor and is a valid and legally binding obligation of the Guarantor, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles. 
 (ix) The Guarantor is not an “ineligible issuer” as defined under the Securities Act at the times specified in the Securities Act in connection with the offering of the Securities. 

3. Purchase, Sale and Delivery of Initial Securities. On the basis of the representations, warranties and agreements herein
contained, but subject to the terms and conditions herein set forth, the Company agrees to sell to the several Underwriters, and each Underwriter agrees to purchase, severally and not jointly, from the Company, the respective principal amount of
Securities set forth opposite such Underwriter’s name on Schedule II hereto at the purchase price set forth thereon, plus accrued interest, if any, from the date specified in Schedule I hereto to the date of payment and delivery, and the
Guarantors agree to issue the Guarantees with respect to the Securities. 
 The Company understands that the several
Underwriters intend (i) to make a public offering of their respective portions of the Securities and (ii) initially to offer the Securities upon the terms set forth in the Registration Statement, the Time of Sale Information and the
Prospectus. 
 The Issuers will deliver, against payment of the purchase price, the Securities in the form of one or more
permanent global securities in definitive form (the “Global Securities”) deposited with the Trustee as custodian for The Depository Trust Company (“DTC”) and registered in the name of Cede & Co. as nominee
for DTC. Interests in any permanent Global Securities will be held only in book-entry form through DTC, except in the limited circumstances described in the Registration Statement, the Time of Sale Information and the Prospectus. Payment for the
Securities shall be made by the Underwriters by wire transfer in immediately available funds to an account specified by the Company on the date and at the time set forth in Schedule I hereto, or at such other time not later than five full business
days thereafter as the Underwriters and the Company may agree in writing, such time being herein referred to as the “Closing Date,” against delivery to the Trustee as custodian for DTC of the Global Securities representing all of
the Securities. The Global Securities will be made available for checking by the Representatives at such place as the Representatives and the Company agree not later than 1:00 P.M. New York City Time, on the Business Day prior to the Closing Date.

  
 13 

 The Company acknowledges and agrees that the Underwriters are acting solely in the capacity
of an arm’s length contractual counterparty to the Company and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person, in each case, with respect to the offering of Securities contemplated hereby
(including in connection with determining the terms of the offering). Additionally, no such Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction with respect
to the offering of Securities contemplated hereby. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the offering of Securities contemplated
hereby, and such Underwriters shall have no responsibility or liability to the Company with respect to any information or advice received by the Company from its own advisors concerning such matters or arising out of its own independent
investigation and appraisal of the offering of Securities contemplated hereby. Any review by such Underwriters named in the Underwriting Agreement of the Company, the transactions contemplated thereby or other matters relating to such transactions
will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. 
 4. Certain
Agreements of the Issuers. The Issuers, jointly and severally, agree with each of the several Underwriters that: 
 (a) The Issuers will b) pay the registration fees for this offering within the time period required by Rule 456(b)(1)(i) under the Securities Act (without giving effect to the proviso therein) and in
any event prior to the Closing Date and c) file the Prospectus in a form approved by the Representatives pursuant to Rule 424 under the Securities Act not later than the Commission’s close of business on the second Business Day following the
date of determination of the offering price of the Securities or, if applicable, such earlier time as may be required by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act. The Company will file any Issuer Free Writing Prospectus
(including the Term Sheet in the form of Schedule VII to the Underwriting Agreement) to the extent required by Rule 433 under the Securities Act; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the
extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request.

 (b) The Issuers will advise the Representatives promptly after obtaining knowledge, and, if requested by the
Representatives, confirm in writing, d) when any amendment to the Registration Statement has been filed or becomes effective; e) when any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus

  
 14 

 
has been filed; f) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the
Commission relating to the Registration Statement or any other request by the Commission for any additional information; g) of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or
suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; h) of the occurrence of any event within the Prospectus
Delivery Period (as defined below in Section 4(c)) as a result of which (A) the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a Purchaser, not misleading, or (B) the Time of Sale Information or any Issuer Free Writing Prospectus as then
amended and supplemented would include any untrue statement of a material fact or omit to state a material necessary in order to make the statements therein, in the light of the circumstances existing when the Time of Sale Information or any Issuer
Free Writing Prospectus is delivered to a Purchaser, not misleading; i) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the Securities Act and j) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement (as described in clause (iv) above), preventing or suspending the use of any
Preliminary Prospectus or the Prospectus (as described in clause (iv) above) or suspending any such qualification of the Securities (as described in clause (iv) above) and, if any such order is issued, will obtain as soon as possible the
withdrawal thereof. 
 (c) The Company will deliver, without charge, to each Underwriter during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto) and each Issuer Free Writing Prospectus (if applicable) as the Representatives may reasonably request. As used herein, the term
“Prospectus Delivery Period” means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the Securities is required by law to be
delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. 

  
 15 

 (d) Before making, preparing, using, authorizing, approving, referring to or
filing any Issuer Free Writing Prospectus during the Prospectus Delivery Period, and before filing any amendment or supplement to the Registration Statement or the Prospectus, the Company will furnish to the Representatives and counsel for the
Underwriters, within a reasonable time prior to the filing thereof with the Commission, a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not during the Prospectus Delivery Period make, prepare, use,
authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement (other than any document required to be filed with the Commission under the Exchange Act and incorporated by reference
into the Registration Statement or Prospectus) to which the Representatives reasonably objects. 
 (e) If at any
time prior to the Closing Date k) any event shall occur or condition shall exist as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading or l) it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will promptly notify
the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or
supplements to the Time of Sale Information as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the circumstances then prevailing, be misleading or so that the Time of
Sale Information will comply with law. 
 (f) If during the Prospectus Delivery Period m) any event shall occur
or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or n) it is necessary to amend or supplement the Prospectus to comply with law, the Company will immediately notify the
Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Prospectus
as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with
law. 

  
 16 

 (g) The Issuers will arrange for the qualification of the Securities for
sale and the determination of their eligibility for investment under the laws of such states in the United States as the Representatives may reasonably designate and will continue such qualifications in effect so long as reasonably required for the
distribution of the Securities by the Underwriters; provided that in connection therewith none of the Issuers will be required to qualify as a foreign corporation or to file a general consent to service of process in any such state. 

(h) The Company will make generally available to its security holders and the Representatives an earnings statement that
satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the
“effective date” (as defined in Rule 158) of the Registration Statement. 
 (i) During the
period of two years after the Closing Date, none of the Issuers will be or become, an open-end investment company, unit investment trust or face-amount certificate company that is or is required to be registered under Section 8 of the
Investment Company Act. 
 (j) The Company will pay all expenses incidental to the performance of the
Issuers’ obligations under this Agreement and the Indenture including o) the fees and expenses of the Trustee and its professional advisers; p) all expenses in connection with the execution, issue, authentication, packaging and delivery of the
Securities, the preparation and printing of this Agreement, the Securities, the Indenture, the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus and amendments and
supplements thereto, and any other document relating to the issuance, offer, sale and delivery of the Securities; q) the cost of any advertising approved by the Company in connection with the issue of the Securities, r) any expenses (including the
reasonable fees and disbursements of counsel) incurred in connection with qualification of the Securities for sale under the laws of such jurisdictions as the Representatives designate (subject to the limitations set forth in paragraph
(g) above) and the printing of memoranda relating thereto, s) any fees charged by investment rating agencies for the rating of the Securities, and t) expenses incurred in distributing the Time of Sale Information and the Prospectus (including
any amendments and supplements thereto) to the 

  
 17 

 
Representatives. Unless this Agreement is terminated pursuant to Section 10, the Company will reimburse the Underwriters for all travel expenses of the Underwriters and the Company’s
officers and employees and any other expenses of the Underwriters and the Company in connection with attending or hosting meetings with prospective purchasers of the Securities. 

(k) In connection with the offering, until and including the Business Day following the Closing Date, neither the Issuers
nor any of their affiliates have or will, either alone or with one or more other persons, bid for or purchase for any account in which they or any of their affiliates have a beneficial interest in any Securities or attempt to induce any person to
purchase any Securities; and neither they nor any of their affiliates will make bids or purchases for the purpose of creating actual, or apparent, active trading in, or of raising the price of, the Securities. 

(l) The Company will not offer, sell, contract to sell, or otherwise dispose of, directly or indirectly, or file with the
Commission a registration statement under the Securities Act relating to, United States dollar-denominated debt securities issued or guaranteed by the Company and having a maturity of more than one year from the date of issue, other than under any
credit facility of the Company, without the prior written consent of the Representatives, which shall not be unreasonably withheld or delayed, for a period beginning at the time of execution of this Agreement and ending on the Closing Date or the
failure of the consummation of the purchase and sale of the Securities as contemplated by Section 3 hereof. 

(m) The Company will file all reports and any definitive proxy or information statements required to be filed by the
Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act during the Prospectus Delivery Period. 
 (n) The Company will retain copies of each Issuer Free Writing Prospectus it has used that is not filed with the Commission in accordance with, and to the extent provided in Rule 433 under the Securities
Act. 
 5. Certain Agreements of the Underwriters. Each Underwriter represents and agrees that: 

(a) It has not and will not use, authorize use of, refer to, or participate in the planning for use of, any
“free writing prospectus”, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and 

  
 18 

 
not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i) a free writing prospectus that, solely as a result of use by such
Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on Schedule III to the Underwriting Agreement or prepared pursuant to
Sections 2(a)(iii), 2(b)(iii) or Section 4(d) above (including any electronic road show), or (iii) any free writing prospectus prepared by such Underwriter and approved by the Company in advance in writing. 

(b) Notwithstanding the foregoing the Underwriters may use a term sheet substantially in the form of Schedule VII to the
Underwriting Agreement without the consent of the Company. 
 (c) It will abide by the offering restrictions as
set forth on Schedule VIII hereto. 
 6. Conditions of the Obligations of the Underwriters. The several obligations of
the Underwriters to purchase and pay for the Securities will be subject to the performance by the Issuers of their respective obligations hereunder and to the following additional conditions precedent: 

(a) If a post-effective amendment to the Registration Statement is required to be filed under the Securities Act,
such post-effective amendment shall have become effective, and the Representatives shall have received notice thereof, not later than 5:00 P.M., New York City time, on the date of the Underwriting Agreement; if applicable, the Rule 462(b)
Registration Statement shall have become effective by 10:00 a.m. New York City time on the business day following the date of the Underwriting Agreement; no order suspending the effectiveness of the Registration Statement shall be in effect, and no
proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section 4(a) hereof; and all requests by the Commission
for additional information shall have been complied with to the reasonable satisfaction of the Representatives. 

(b) The representations and warranties of the Issuers contained herein shall be true and correct on the date hereof and on
and as of the Closing Date; and the statements of the Issuers and their officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date. 

  
 19 

 (c) Subsequent to the earlier of (A) the Time of Sale and (B) the
execution and delivery of this Agreement, u) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by the Company or the Guarantors by any “nationally
recognized statistical rating organization”, as such term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act and v) no such organization shall have publicly announced that it has under surveillance or review,
or has changed its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock of or guaranteed by the Company or the Guarantors, in each case with respect to the Company and the Guarantors, with negative
implications of a possible downgrading. 
 (d) No event or condition of a type described in
Section 2(a)(vi)(a) hereof shall have occurred or shall exist, which event or condition is not described in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement
thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of
Sale Information and the Prospectus. 
 (e) Jenner & Block LLP, counsel for the Issuers, shall have
furnished to the Representatives, at the request of the Company, their written opinion and 10b-5 Statement, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect
set forth in Schedule V attached hereto. 
 (f) The Representatives shall have received an opinion, dated the
Closing Date, from Gregory S. Gallopoulos, Senior Vice President and General Counsel of the Company, in the form of Schedule VI attached hereto. 
 (g) The Representatives shall have received on and as of the Closing Date an opinion and 10b-5 Statement of Davis Polk & Wardwell LLP, counsel for the Underwriters, with respect to such matters
as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request from the Company to enable them to pass upon such matters. 

(h) No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued
by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction or order of any federal, state or foreign court shall have been issued that
would, as of the Closing Date, prevent the issuance or sale of the Securities. 

  
 20 

 (i) The Representatives shall have received on and as of the Closing Date
satisfactory evidence of the good standing of the Issuers in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any standard
form of telecommunication from the appropriate governmental authorities of such jurisdictions. 
 (j) The
Representatives shall have received on and as of the Closing Date a certificate of an executive officer of the Company (which certificate shall be executed on behalf of the Company, and not in such officer’s personal capacity) who has specific
knowledge of the Company’s financial matters and is reasonably satisfactory to the Representatives in which such officer, to the best of his or her knowledge after reasonable investigation, shall w) confirm that such officer has carefully
reviewed the Registration Statement, the Time of Sale Information and the Prospectus and, to the best knowledge of such officer, the representations set forth in Sections 2(a)(i) and 2(a)(ii) hereof are true and correct, x) confirm that the other
representations and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing
Date and y) certify to the effect set forth in paragraphs (a) and (c) above. 
 (k) The Representatives
shall have received a certificate, dated the Closing Date, of an executive officer of each of the Guarantors (which certificate shall be executed on behalf of the Company, and not in such officer’s personal capacity) in which such officer, to
the best of his or her knowledge after reasonable investigation, shall state that the representations and warranties of such Guarantor in this Agreement are true and correct in all material respects, and that such Guarantor has, in all material
respects, complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date. 
 (l) On the date of this Agreement and on the Closing Date, KPMG LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants’ “comfort letters” to

  
 21 

 
underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus; provided that the letter delivered on the Closing Date shall use a “cut-off” date no more than three business days prior to the Closing Date. 
 The Issuers will furnish the Representatives with such conformed copies of such opinions, certificates, letters and documents as the Representatives reasonably request. The Representatives may in their
sole discretion waive on behalf of the Representatives compliance with any conditions to the obligations of the Representatives hereunder. 
 7. Indemnification. 
 (a) The Issuers agree to indemnify and
hold harmless the Underwriters and each person, if any, who controls the Underwriters within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act against any and all losses, liabilities, claims, damages and
expenses as incurred (including but not limited to reasonable attorneys’ fees and any and all reasonable expenses incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim, and subject to
subsection (c) of this Section 7, any and all amounts paid in settlement of any claim or litigation), to which they or any of them may become subject under the Securities Act, the Exchange Act or any other federal or state statutory law or
regulation, at common law or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon z) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement, or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, not misleading, or aa) any untrue statement or alleged
untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged omission to state therein a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case under clause (i) or (ii) except insofar as such losses, claims, damages liabilities or expenses
arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use therein. 

  
 22 

 (b) Each Underwriter agrees, severally and not jointly, to indemnify and
hold harmless the Issuers, their respective directors and officers and each person, if any, who controls any of the Issuers within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all
losses, liabilities, claims, damages and expenses as incurred (including but not limited to reasonable attorney’s fees and any and all reasonable expenses incurred in investigating, preparing or defending against any litigation, commenced or
threatened, or any claim, and subject to subsection (c) of this Section 7, any and all amounts paid in settlement of any claim or litigation), to which they or any of them may become subject under the Securities Act, the Exchange Act or
any other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or action in respect thereof) arise out of or are based upon, any untrue statement or omission or
alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Issuers in writing by such Underwriter through the Representatives expressly for use in the Registration
Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that the only such information consists of the information identified in the
Underwriting Agreement as being provided by the Underwriters. The Issuers acknowledge that the information identified as “Underwriter Information” on Schedule I hereto constitutes the only information furnished in writing by the
Underwriters or the Representatives expressly for use in the Prospectus, or any amendment or supplement thereto, as the case may be. 
 (c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is
to be made against the indemnifying party under such subsection, notify each party against whom indemnification is to be sought in writing of the commencement of such action (but the failure so to notify an indemnifying party shall not relieve it
from any liability which it may have under this Section 7). In case any such action is brought against any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to
participate therein, and to the extent it may elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to
such indemnified party. Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its or their own counsel in any such case, but the fees 

  
 23 

 
and expenses of such counsel shall be at the expense of such indemnified party or parties unless bb) the employment of such counsel shall have been authorized in writing by one of the
indemnifying parties in connection with the defense of such action, cc) the indemnifying parties shall not have employed counsel to have charge of the defense of such action within a reasonable time after notice of commencement of the action, or dd)
such indemnified party or parties shall have been advised by counsel that there may be defenses available to it or them which are different from or additional to those available to one or all of the indemnifying parties (in which case the
indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the indemnifying parties. In no event shall the
indemnifying party or parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or
related actions in the same jurisdiction arising out of the same general allegations or circumstances. The indemnifying party shall indemnify and hold harmless the indemnified party from and against any and all losses, claims, damages, liabilities
and judgments by reason of any settlement of any action ee) effected with its written consent or ff) effected without its written consent if (1) the settlement is entered into more than 20 business days after the indemnifying party shall have
received a request from the indemnified party for reimbursement for the fees and expenses of counsel (in any case where such fees and expenses are at the expense of the indemnifying party), (2) such indemnifying party shall have received notice
of the terms of such settlement at least 20 business days prior to such settlement being entered into and (3) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such
settlement. Notwithstanding the immediately preceding sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel (in any case where such fees and
expenses are at the expense of the indemnifying party), an indemnifying party shall not be liable for any settlement of the nature contemplated by this Section 7(c) effected without its consent if such indemnifying party gg) reimburses such
indemnified party in accordance with such request to the extent that it considers such request to be reasonable and hh) provides written notice to the indemnified party substantiating the unpaid balance as unreasonable, in each case prior to the
date of such settlement. 

  
 24 

 8. Contribution. In order to provide for contribution in circumstances in which the
indemnification provided for in Section 7 hereof is for any reason held to be unavailable from any indemnifying party or is insufficient to hold harmless a party indemnified thereunder, the Issuers and the Underwriters shall contribute to the
aggregate losses, claims, damages, liabilities and expenses of the nature contemplated by such indemnification provision (including any reasonable investigation, legal and other expenses incurred in connection with, and, subject to the last sentence
of this Section 8, any amount paid settlement of, any action, suit or proceeding or any claims asserted, but after deducting in the case of losses, claims, damages, liabilities and expenses suffered by the Issuers any contribution received by
the Issuers from persons, other than the Underwriters, who may also be liable for contribution, including persons who control any of the Issuers within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act)
as incurred to which the Issuers and the Underwriters may be subject, in such proportions as is appropriate to reflect the relative benefits received by the Issuers and the Underwriters from the offering of the Securities or, if such allocation is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to above but also the relative fault of the Issuers and the Underwriters in connection with the statements or omissions which
resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits received by the Issuers and the Underwriters shall be deemed to be in the same proportion as
(x) the total proceeds from the offering (net of discounts and commissions but before deducting expenses) received by the Company and (y) the discounts and commissions received by the Underwriters, respectively, in each case as set forth
in the table on the cover page of the Prospectus. The relative fault of the Issuers and of the Underwriters shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Issuers or the Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission or
any violation of the nature referred to in Section 7(a). The Issuers and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined by pro rata allocation or by any other
method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this Section 8, 2) in no case shall the Underwriters be liable or responsible for any amount in excess of the
discount applicable to the Securities purchased by the Underwriters hereunder, and 3) no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. Notwithstanding the provisions of this Section 8 and the preceding sentence, the Underwriters shall not be required to contribute any amount in excess of the amount by which the total
price at which the Securities purchased by it and resold exceeds the amount of any damages that it has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. For purposes of this
Section 8, each person, if any, who controls the Underwriters within the meaning 

  
 25 

 
of Section 15 of the Securities Act or Section 20(a) of the Exchange Act shall have the same rights to contribution as the Underwriters, and each person, if any, who controls any of the
Issuers within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, shall have the same rights to contribution as the Issuers, subject in each case to clauses 2) and 3) of this Section 8. Any party
entitled to contribution will, promptly after receipt of notice of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may be made against another party or parties, notify each party or
parties from whom contribution may be sought, but the omission to so notify such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation it or they may have under this Section 8 or
otherwise. No party shall be liable for contribution with respect to any action or claim settled without its written consent; provided, however, that such consent was not unreasonably withheld. 

9. Termination. This Agreement may be terminated in the absolute discretion of the Representatives, by written notice to the
Company, if after the execution and delivery of this Agreement and prior to the Closing Date 4) trading generally shall have been suspended or materially limited on the New York Stock Exchange or the over-the-counter market; 5) trading of any
securities issued or guaranteed by the Company shall have been suspended on the New York Stock Exchange; 6) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; (d) there shall
have occurred a material disruption in commercial banking or securities settlement or clearing services; or (e) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis,
either within or outside the United States; provided that, in the case of clauses (d) and (e) above, the occurrence of such event is, in the judgment of the Representatives, material and adverse and makes it impracticable or
inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus. 

10. Defaulting Underwriter. 7) If, on the Closing Date, any Underwriter defaults on its obligation to purchase the Securities that
it has agreed to purchase hereunder, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after
any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the
non-defaulting Underwriters to purchase such Securities on such terms. If other persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the non defaulting Underwriters or the Company may postpone the Closing
Date for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the 

  
 26 

 
Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to
the Registration Statement and the Prospectus that effects any such changes. 
 (a) If, after giving effect to
any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph 7) above, the aggregate principal amount of such Securities that remains
unpurchased does not exceed 10% of the aggregate principal amount of all the Securities, then the Company shall have the right to require each non-defaulting Underwriter to purchase the principal amount of Securities that such Underwriter agreed to
purchase hereunder plus such Underwriter’s pro rata share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such
arrangements have not been made. 
 (b) If, after giving effect to any arrangements for the purchase of the
Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph 7) above, the aggregate principal amount of such Securities that remains unpurchased exceeds 10% of the aggregate
principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (a) above, then this Agreement shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of
this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section 4(j) hereof and except that the
provisions of Section 7 and Section 8 hereof shall not terminate and shall remain in effect. 
 (c)
Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused by its default. 

(d) As used in this Agreement, the term “Underwriter” includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in the Underwriting Agreement that, pursuant to this Section 10, purchases Securities that a defaulting Underwriter agreed but failed to purchase. 

  
 27 

 11. Survival of Certain Representations and Obligations. The respective indemnities,
agreements, representations, warranties and other statements of the Issuers or their officers and of the Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation, or statement
as to the results thereof, made by or on behalf of the Underwriters, the Issuers or any of their respective representatives, officers or directors or any controlling person, and will survive delivery of and payment for the Securities. If for any
reason the purchase of the Securities by the Underwriters is not consummated, the Issuers shall remain responsible for their own expenses to be paid or reimbursed by it pursuant to Section 4(j) and the respective obligations of the Issuers and
the Underwriters pursuant to Sections 7 and 8 shall remain in effect. If the purchase of the Securities by the Underwriters is not consummated for any reason other than solely because of the occurrence of any event specified in clause (a), (c),
(d) or (e) of Section 9, and other than as a result of the termination of this Agreement pursuant to Section 10, the Company will reimburse the Underwriters for all out-of-pocket expenses (including fees and disbursements of
counsel) reasonably incurred by it in connection with the offering of the Securities. 
 12. Notices. All communications
hereunder will be in writing and, if sent to the Underwriters will be mailed, delivered or telegraphed and confirmed to the Representatives at the address appearing in Schedule I hereto, or, if sent to the Issuers, will be mailed, delivered or
telegraphed and confirmed to the Company at 2941 Fairview Park Drive, Suite 100, Falls Church, VA 22042-4513, Attention: General Counsel; provided, however, that any notice to the Representatives pursuant to Sections 7 and 8 will be
mailed, delivered or telegraphed and confirmed to the Representatives. 
 13. Patriot Act. In accordance with the
requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which
information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. 

14. Successors. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the controlling persons referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or
any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of such purchase. 
 15. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same
Agreement. 

  
 28 

 16. Applicable Law. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of New York without regard to principles of conflicts of laws. 

  
 29 

 If the foregoing is in accordance with your understanding of our agreement, kindly sign and
return to the Company one of the counterparts hereof, whereupon it will become a binding agreement among the Issuers and the Underwriters in accordance with its terms. 

 

					
	 Very truly yours,
  

GENERAL DYNAMICS CORPORATION

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Vice President and Treasurer
	  
 AMERICAN OVERSEAS MARINE
CORPORATION

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Vice President and Treasurer
	  
 BATH IRON WORKS CORPORATION

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 ELECTRIC BOAT CORPORATION

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 GENERAL DYNAMICS ARMAMENT AND TECHNICAL PRODUCTS,
INC.

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer

 [Signature Page to the Underwriting Agreement] 

 
					
	GENERAL DYNAMICS GOVERNMENT SYSTEMS CORPORATION
		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 GENERAL DYNAMICS LAND SYSTEMS
INC.

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 GENERAL DYNAMICS ORDNANCE AND TACTICAL SYSTEMS,
INC.

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 GULFSTREAM AEROSPACE CORPORATION

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer
	  
 NATIONAL STEEL AND SHIPBUILDING
COMPANY

		
	By:	 	/s/ David H. Fogg
		 	Name:	 	David H. Fogg
		 	Title:	 	Treasurer

 [Signature Page to the Underwriting Agreement] 

					
	 The foregoing Underwriting Agreement is hereby confirmed and accepted as of the date first above written.

 
 Merrill Lynch, Pierce, Fenner & Smith

Incorporated

		
	By:	 	/s/ Happy Daily
		 	Name:	 	Happy Daily
		 	Title:	 	Managing Director
	  
 J.P. Morgan Securities LLC

		
	By:	 	/s/ ROBERT BOTTAMEDI
		 	Name:	 	ROBERT BOTTAMEDI
		 	Title:	 	VICE PRESIDENT
	  
 RBS Securities Inc.

		
	By:	 	/s/ STEVEN FITZPATRICK
		 	Name:	 	STEVEN FITZPATRICK
		 	Title:	 	MANAGING DIRECTOR
	  
 Wells Fargo Securities, LLC

		
	By:	 	/s/ Carolyn Hurley
		 	Name:	 	Carolyn Hurley
		 	Title:	 	Director

 (Signature Page to the Underwriting Agreement) 

 SCHEDULE I 

 

			
	Representatives:	  	Merrill Lynch, Pierce, Fenner & Smith
		  	 Incorporated

		  	J.P. Morgan Securities LLC
		  	RBS Securities Inc.
		  	Wells Fargo Securities, LLC
		
	Underwriting Agreement dated:	  	July 5, 2011
		
	Registration Statement No.:	  	333-155980
		
	Indenture:	  	The Indenture dated as of August 27, 2001, by and among the Company, the Guarantors and The Bank of New York Mellon, as trustee, as supplemented by the Sixth Supplemental
Indenture to be dated as of July 12, 2011 among the Company, the Guarantors and The Bank of New York Mellon
	
	Title, Purchase Price and Description of 2015 Notes:
		
	 Title:
	  	1.375% Notes due 2015
		
	 Principal amount:
	  	$500,000,000
		
	 Purchase Price:
	  	$497,950,000
		
	 Price to Public:
	  	99.840% of the principal amount of the Securities, plus accrued interest, if any, from July 12, 2011 to the Closing Date
		
	 Maturity:
	  	January 15, 2015
		
	 Interest Rate:
	  	1.375%
		
	 Interest Payment Dates:
	  	January 15 and July 15 beginning January 15, 2012
	
	Title, Purchase Price and Description of 2016 Notes:
		
	 Title:
	  	2.250% Notes due 2016

  
 I - 1

			
		
	 Principal amount:
	  	$500,000,000
		
	 Purchase Price:
	  	$497,635,000
		
	 Price to Public:
	  	99.877% of the principal amount of the Securities, plus accrued interest, if any, from July 12, 2011 to the Closing Date
		
	 Maturity:
	  	July 15, 2016
		
	 Interest Rate:
	  	2.250%
		
	 Interest Payment Dates:
	  	January 15 and July 15 beginning January 15, 2012
	
	Title, Purchase Price and Description of 2021 Notes:
		
	 Title:
	  	3.875% Notes due 2021
		
	 Principal amount:
	  	$500,000,000
		
	 Purchase Price:
	  	$496,925,000
		
	 Price to Public:
	  	99.835% of the principal amount of the Securities, plus accrued interest, if any, from July 12, 2011 to the Closing Date
		
	 Maturity:
	  	July 15, 2021
		
	 Interest Rate:
	  	3.875%
		
	 Interest Payment Dates:
	  	January 15 and July 15 beginning January 15, 2012
		
	Closing Date:	  	July 12, 2011
		
	Closing Location:	  	Davis Polk & Wardwell LLP, 450
		  	Lexington Avenue, New York, New
		  	York 10017
		
	Address for Notices to Underwriters:	  	Merrill Lynch, Pierce, Fenner & Smith
		  	 Incorporated

		  	One Bryant Park
		  	NY1-100-18-03
		  	New York, New York 10036

  
 I-2

			
		  	Attention: High Grade Transaction
		  	Management/Legal
		  	Facsimile:   (646) 855-5958
		
		  	J.P. Morgan Securities LLC
		  	383 Madison Avenue
		  	New York, New York 10179
		  	Attention: Investment Grade Syndicate
		  	Desk
		  	Facsimile:   (212) 834-6081
		
		  	RBS Securities Inc.
		  	600 Washington Boulevard
		  	Stamford, CT 06901
		  	Fax: 203-873-4534
		  	Attention: Debt Capital Markets
		  	Syndicate
		
		  	Wells Fargo Securities, LLC
		  	301 S. College Street
		  	Charlotte, NC 28288
		  	Facsimile: 704-383-9165
		  	Attention: Transaction Management
		
	 Underwriter Information in the Prospectus:
	  	 a)      The third paragraph of text under the caption “Underwriting” in the
Preliminary Prospectus Supplement and the Prospectus Supplement concerning the terms of offering, including the concession and reallowance to certain dealers, by the Underwriters;

		
		  	 b)      The third and fourth sentences of the fifth paragraph of text under the caption
“Underwriting” in the Preliminary Prospectus Supplement and the Prospectus Supplement relating to market making by the Underwriters;

  
 I-3

			
		  	 and

		
		  	 c)      The sixth and seventh paragraphs of text under the caption “Underwriting” in
the Preliminary Prospectus Supplement and the Prospectus Supplement relating to over-allotment and stabilization by the Underwriters and penalty bids that may be imposed by the Underwriters.

  
 I-4

 SCHEDULE II 

 

																									
	 Underwriter
	  	Purchase Price of
2015 Notes	 	  	Aggregate
Principal Amount
of 2015 Notes	 	  	Purchase Price of
2016 Notes	 	  	Aggregate
Principal Amount
of 2016 Notes	 	  	Purchase Price of
2021 Notes	 	  	Aggregate
Principal Amount
of 2021 Notes	 
	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
	  	$	59,754,000	  	  	$	60,000,000	  	  	$	59,716,200	  	  	$	60,000,000	  	  	$	59,631,000	  	  	$	60,000,000	  
	 J.P. Morgan Securities LLC
	  	$	59,754,000	  	  	$	60,000,000	  	  	$	59,716,200	  	  	$	60,000,000	  	  	$	59,631,000	  	  	$	60,000,000	  
	 RBS Securities Inc
	  	$	59,754,000	  	  	$	60,000,000	  	  	$	59,716,200	  	  	$	60,000,000	  	  	$	59,631,000	  	  	$	60,000,000	  
	 Wells Fargo Securities, LLC
	  	$	59,754,000	  	  	$	60,000,000	  	  	$	59,716,200	  	  	$	60,000,000	  	  	$	59,631,000	  	  	$	60,000,000	  
	 Banco Bilbao Vizcaya Argentaria, S.A.
	  	$	59,754,000	  	  	$	60,000,000	  	  	$	59,716,200	  	  	$	60,000,000	  	  	$	59,631,000	  	  	$	60,000,000	  
	 Goldman, Sachs and Co.
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 Lazard Capital Markets LLC
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 Lloyds Securities Inc.
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 Mitsubishi UFJ Securities (USA), Inc.
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 Mizuho Securities USA Inc.
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 U.S. Bancorp Investments, Inc.
	  	$	17,428,250	  	  	$	17,500,000	  	  	$	17,417,225	  	  	$	17,500,000	  	  	$	17,392,375	  	  	$	17,500,000	  
	 ANZ Securities, Inc.
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 Barclays Capital Inc.
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 BNY Mellon Capital Markets, LLC
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 Cowen and Company, LLC
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 PNC Capital Markets LLC
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 SMBC Nikko Capital Markets Limited
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 SunTrust Robinson Humphrey, Inc.
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 TD Securities (USA) LLC
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 The Williams Capital Group, L.P.
	  	$	9,959,000	  	  	$	10,000,000	  	  	$	9,952,700	  	  	$	10,000,000	  	  	$	9,938,500	  	  	$	10,000,000	  
	 Scotia Capital (USA) Inc
	  	$	4,979,500	  	  	$	5,000,000	  	  	$	4,976,350	  	  	$	5,000,000	  	  	$	4,969,250	  	  	$	5,000,000	  
		  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
	 Total:
	  	$	497,950,000	  	  	$	500,000,000	  	  	$	497,635,000	  	  	$	500,000,000	  	  	$	496,925,000	  	  	$	500,000,000	  
		  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 

  
 II-1

 SCHEDULE III 
 Time of Sale Information 
  

	1.	Preliminary Prospectus dated July 5, 2011 

  

	2.	Pricing Term Sheet dated July 5, 2011 

  
 III-1

 SCHEDULE IV 
 GUARANTORS 
 American Overseas Marine Corporation, a Delaware corporation 

Bath Iron Works Corporation, a Maine corporation 
 Electric Boat Corporation, a Delaware corporation 
 General Dynamics Armament and Technical
Products, Inc., a Delaware corporation 
 General Dynamics Government Systems Corporation, a Delaware corporation 

General Dynamics Land Systems Inc., a Delaware corporation 
 General Dynamics Ordnance and Tactical Systems, Inc., a Virginia corporation 
 Gulfstream
Aerospace Corporation, a Delaware corporation 
 National Steel and Shipbuilding Company, a Nevada corporation 

  
 IV-1

 SCHEDULE V 
 OPINION OF JENNER & BLOCK LLP 

[                 ], 20[    ]

 [The Representatives] 
 as
representatives of the several Underwriters 
 party to the Underwriting Agreement 
 Ladies and Gentlemen: 
 We are issuing this letter in our capacity as special
counsel for General Dynamics Corporation (the “Corporation”) in response to the requirement of Section 6(e) of the Underwriting Agreement dated [            
    ], 20[    ] (the “Underwriting Agreement”) by and among the Corporation, the guarantors named therein (the “Guarantors” and, together with the Corporation,
the “Issuers”) and [the Representatives], as representatives of the several Underwriters party thereto (the “Representatives”). The Underwriting Agreement relates to the offering (the “Offering”) of
certain [Title of Debt Securities], including the guarantees of the Guarantors related thereto (the “Securities”). Every term which is defined or given a special meaning in the Underwriting Agreement and which is not given a
different meaning in this letter has the same meaning whenever it is used in this letter as the meaning it is given in the Underwriting Agreement. 
 In connection with the preparation of this letter, we have among other things read: 

(a) the Registration Statement on Form S-3 (Registration No. 333-155980) filed by the Corporation with the Securities and
Exchange Commission (the “Commission”) for the purpose of registering the Offering under the Securities Act of 1933, as amended (the “Securities Act”) (which registration statement, as amended and including the
information incorporated therein by reference and the information deemed to be part of the registration statement at the time of effectiveness pursuant to Rule 430B under the Securities Act, and as constituted at the Effective Time, is herein called
the “Registration Statement”); 
 (b) the Prospectus of the Corporation dated December 8, 2008 (the
“Basic Prospectus”) and the Preliminary Prospectus Supplement thereto dated [         ], 20[     ] (which Basic Prospectus and Preliminary Prospectus Supplement, including
the information incorporated therein by reference, are herein collectively called the “Preliminary Prospectus”); 

  
 V-1

 (c) the Basic Prospectus and the Prospectus Supplement thereto dated
[                 ], 20[    ] (which Basic Prospectus and Prospectus Supplement, including the information incorporated therein
by reference, are herein collectively called the “Prospectus”); 
 (d) the reports filed by the
Corporation pursuant to the Exchange Act and incorporated by reference into the Preliminary Prospectus and the Prospectus; 

(e) the Indenture, dated as of August 27, 2001 (the “Indenture”) by and among the Corporation, the Guarantors
and The Bank of New York Mellon (formerly The Bank of New York), as trustee (the “Trustee”), and the [            ] Supplemental Indenture thereto, dated as of
[                 ], 20[    ] (the “[            ]
Supplemental Indenture”); 
 (f) an executed copy of the Underwriting Agreement; 

(g) a specimen of the Securities; 
 (h) a copy of the resolutions of the Board of Directors of the Corporation adopted on [            ] 

(i) a copy of the resolutions of the Board of Directors of each of the Guarantors adopted on
[            ]; 
 (j) a copy of the Restated
Certificate of Incorporation of the Corporation, as amended, certified as of a recent date by the Secretary of State of Delaware; 
 (k) a copy of the Amended and Restated By-laws of the Corporation, as amended; and 
 (l) copies of all certificates and other documents delivered today in connection with the consummation of the Offering. 
 Subject to the assumptions, qualifications and limitations which are identified in this letter, we advise you that: 
 (i) (A) The Registration Statement is an “automatic shelf registration statement” as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier
than three years prior to the date hereof; (B) (i) to our knowledge no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities
Act has been received by the Company and (ii) the Indenture was qualified under the Trust Indenture Act; (C) each of the Preliminary Prospectus and the Prospectus was filed with the Commission pursuant to Rule 424(b)

  
 V-2

 
under the Securities Act; and (D) to our knowledge no order suspending the effectiveness of the Registration Statement has been issued, no notice of objection of the Commission to the use of
such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against
the Company or in connection with the offering has been initiated or threatened by the Commission. 
 (ii) the
Corporation is validly existing as a corporation in good standing under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct its business as described in the Registration Statement, the Time of Sale
Information and the Prospectus; 
 (iii) (A) (1) the Indenture has been duly authorized, executed
and delivered by the Issuers; (2) the Securities have been duly authorized, executed and delivered by the Issuers; (3) the Indenture and the Securities, assuming due authentication, execution and delivery thereof by the Trustee and receipt
of consideration by the Corporation therefore as contemplated by the Underwriting Agreement, constitute valid and legally binding obligations of the Issuers enforceable in accordance with their terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at
law), including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing; and (B) the Indenture and the Securities conform in all material respects to the description thereof contained in the Time of Sale
Information and the Prospectus; 
 (iv) the Underwriting Agreement has been duly authorized, executed and
delivered by the Issuers; 
 (v) the execution, delivery and performance of the Indenture and the
Underwriting Agreement and the issuance and sale of the Securities and the compliance by the Corporation with all of the provisions thereof and the consummation by the Corporation of the transactions contemplated therein on the Closing Date will not
conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument set forth on Schedule A attached hereto
(but no opinion is expressed as to compliance with any financial tests or cross default provisions in any such agreement or other document), except where such conflict, breach, violation or default is not

  
 V-3

 
reasonably likely to have a material adverse change in the condition (financial or otherwise), financial position, stockholders’ equity or results of operations of the Corporation and its
subsidiaries, considered as one enterprise, nor will such action result in any violation of the provisions of the Certificate of Incorporation or By-laws (each as amended) of any of the Issuers or any statute or any order, rule or regulation known
to such counsel of any court or governmental agency or body having jurisdiction over the Issuers or any of their properties (but no opinion is expressed in this paragraph as to compliance with any disclosure requirement or any prohibition against
fraud or misrepresentation or as to whether performance of the indemnification or contribution provisions in the Underwriting Agreement would be permitted); and each of the Issuers has the corporate power and authority to authorize, issue and sell
the Securities as contemplated by the Underwriting Agreement; 
 (vi) the execution, delivery and
performance of the Indenture and the Underwriting Agreement on the Closing Date and the issuance and sale of the Securities and the compliance by the Guarantors with all of the provisions thereof and the consummation by the Guarantors of the
transactions contemplated therein on the Closing Date will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument set forth on Schedule A attached hereto (but no opinion is expressed as to compliance with any financial tests or cross default provisions in any such agreement or other document), except where such conflict, breach,
violation or default is not reasonably likely to have a material adverse change in the condition (financial or otherwise), financial position, stockholders’ equity or results of operations of the Corporation and its subsidiaries, considered as
one enterprise; 
 (vii) no consent, approval, authorization, order, decree, registration or qualification
of or with any such court or governmental agency or body is required for the issuance and sale of the Securities or the consummation by the Issuers of the transactions contemplated by the Underwriting Agreement, except for the qualification of the
Indenture under the Trust Indenture Act; 
 (viii) the statements set forth in the Basic Prospectus under
the caption “Description of the Debt Securities” and the statements set forth in the Preliminary Prospectus Supplement and the Prospectus Supplement under the caption “Description of the Notes and Guarantees” and “Certain
U.S. Federal Tax Consequences,” in each case insofar as such statements constitute summaries of the legal matters, documents or proceedings referred to therein, fairly present in all material respects the information called for with respect to
such legal matters, documents and proceedings; 

  
 V-4

 (ix) the documents incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus or any further amendment or supplement thereto made by the Issuers prior to the Closing Date (other than the financial statements and related notes and schedules and other financial and
statistical data included or incorporated by reference therein or omitted therefrom, as to which we express no opinion), when they became effective or were filed with the Commission, as the case may be, and as amended if such a document has been
amended, appeared on their face to be responsive in all material respects with the requirements of the Exchange Act and the rules and regulations thereunder; 
 (x) the Registration Statement, as of the Effective Time, and each Issuer Free Writing Prospectus included in the Time of Sale Information and the Prospectus, as of the date of the Prospectus
Supplement and as of the date of this letter (other than the financial statements and related notes and schedules and other financial data included or incorporated by reference therein or omitted therefrom, as to which we express no opinion),
appeared on their face to be responsive in all material respects to the requirements of Form S-3; and 

(xi) none of the Issuers is an “investment company,” as such term is defined in the Investment Company Act.

 ••••••••• 

The purpose of our professional engagement was not to establish factual matters, and the preparation of the Registration Statement, the
Time of Sale Information and the Prospectus involved many determinations of a wholly or partially nonlegal character. Except to the extent otherwise explicitly indicated in numbered paragraph (viii) above, we make no representation that we have
independently verified the accuracy, completeness or fairness of the Registration Statement, the Time of Sale Information or the Prospectus or that the actions taken in connection with the preparation of the Registration Statement, the Time of Sale
Information or the Prospectus (including the actions described in the next paragraph) were sufficient to cause the Prospectus, the Time of Sale Information or the Registration Statement to be accurate, complete or fair. We are not passing upon and
do not assume any responsibility for the accuracy, completeness or fairness of the Time of Sale Information, the Prospectus or the Registration Statement, except to the extent otherwise explicitly indicated in numbered paragraph (viii) above.

  
 V-5

 We have participated in the preparation of the Registration Statement, the Time of Sale
Information and the Prospectus. During the course of such preparation, we examined various documents, including those listed at the beginning of our letter, and participated in various conferences with representatives and counsel of the Corporation,
with representatives of the independent accountants for the Corporation and representatives of and counsel to the Underwriters, at which conferences the contents of the Registration Statement, the Time of Sale Information and the Prospectus (and the
documents incorporated therein by reference) were reviewed and discussed. 
 Based on our participation in the conferences and
discussions identified above, our understanding of applicable law and the experience that we have gained in the practice thereunder and relying as to factual matters to the extent we deem appropriate upon the representations and statements of
officers and other representatives of the Corporation, we advise you that no fact came to our attention to cause us to conclude that (i) the Registration Statement, as of the Effective Time, contained an untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) the Time of Sale Information, at the Time of Sale, contained an untrue statement of a material fact or omitted to
state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iii) the Prospectus, as of its date, or as of the date of this letter, contained or
contains an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except for, in each case,
financial statements and schedules and other financial and statistical and similar data and information included therein or incorporated by reference therein or omitted therefrom, as to which we express no opinion. 

••••••••• 
 Except for the activities described in the immediately preceding section of this letter, we have not undertaken any investigation to determine the facts upon which the advice in this letter is based.

 We have assumed for purposes of this letter: each document we have reviewed for purposes of this letter is accurate and
complete, each such document that is an original is authentic, each such document that is a copy conforms to an authentic original, and all signatures on each such document are genuine; that the Underwriting Agreement and every other agreement we
have examined for purposes of this letter constitutes a valid and binding obligation of each party to that document and that each such party has satisfied all legal requirements that are applicable to such party to the extent necessary to entitle
such party to enforce such agreement (except that we make no such assumption with respect to the 

  
 V-6

 
Corporation or the Guarantors); and that you have acted in good faith and without notice of any fact which has caused you to reach any conclusion contrary to any of the advice provided in this
letter. We have also made other assumptions which we believe to be appropriate for purposes of this letter. 
 In preparing this
letter we have relied without independent verification upon: (i) information contained in certificates obtained from governmental authorities; (ii) factual information represented to be true in the Underwriting Agreement, in the other
documents specifically identified at the beginning of this letter as having been read by us and in the certificates and other documents executed by the Corporation and the Guarantors and delivered to you or to the trustee under the Indenture in
connection with the consummation of the Offering; (iii) numbered paragraphs 1 and 5 of the opinion of Gregory S. Gallopoulos, Senior Vice President and General Counsel of the Corporation, with respect to the Offering; (iv) factual
information provided to us by the Corporation or its representatives; and (v) factual information we have obtained from such other sources as we have deemed reasonable. We have assumed that there has been no relevant change or development
between the dates as of which the information cited in the preceding sentence was given and the date of this letter and that the information upon which we have relied is accurate and does not omit disclosures necessary to prevent such information
from being misleading. 
 We confirm that we do not have knowledge that has caused us to conclude that our reliance and
assumptions cited in the two immediately preceding paragraphs are unwarranted. Whenever this letter provides advice about (or based upon) our knowledge of any particular information or about any information which has or has not come to our attention
such advice is based entirely on the conscious awareness at the time this letter is delivered on the date it bears by the lawyers with Jenner & Block LLP at that time who have engaged in substantive representation of the Corporation in
connection with (i) the Offering and (ii) the preparation and filing of reports required to be filed with the Commission by the Corporation pursuant to the Exchange Act and incorporated by reference into the Registration Statement or the
Prospectus. 
 Our advice on every legal issue addressed in this letter is based exclusively on the internal law of the State of
New York, the General Corporation Law of the State of Delaware or the federal law of the United States, and represents our opinion as to how that issue would be resolved were it to be considered by the highest court in the jurisdiction which enacted
such law. With respect to our opinions above, we have assumed, with your permission, that the laws of states of Maine, Nevada and Virginia are the same as the laws of the State of Delaware. Our opinions are limited to the specific issues addressed.
None of the opinions or other advice contained in this letter considers or covers: (i) any foreign or state securities (or “blue sky”) laws or regulations; (ii) any financial statements or supporting schedules (or any
notes to any such statements or 

  
 V-7

 
schedules) or other financial information set forth or incorporated by reference in (or omitted from) the Registration Statement, the Time of Sale Information or the Prospectus; (iii) any
rules and regulations of the Financial Industry Regulatory Authority (FINRA) relating to the compensation of Underwriters; or (iv) the rules and regulations of the New York Stock Exchange, LLC or any other relevant securities exchange. This
letter does not cover any other laws, statutes, governmental rules or regulations or decisions which in our experience are not usually considered for or covered by opinions like those contained in this letter or are not generally applicable to
transactions of the kind covered by the Underwriting Agreement. 
 This letter speaks as of the time of its delivery on the date
it bears. We do not assume any obligation to provide you with any subsequent opinion or advice by reason of any fact about which we did not have knowledge at that time, by reason of any change subsequent to that time in any law, other governmental
requirement or interpretation thereof covered by any of our opinions or advice, or for any other reason. 
 This letter may be
relied upon by the Underwriters only for the purpose served by the provision in the Underwriting Agreement cited in the initial paragraph of this letter in response to which it has been delivered. Without our written consent: (i) no person
other than the Underwriters may rely on this letter for any purpose (except that the Trustee may rely upon paragraph (ii) of this letter in connection with the performance of its obligations under the Indenture to the same extent as if this
letter had been addressed to the Trustee); (ii) this letter may not be cited or quoted in any financial statement, prospectus, private placement memorandum or other similar document; (iii) this letter may not be cited or quoted in any
other document or communication which might encourage reliance upon this letter by any person or for any purpose excluded by the restrictions in this paragraph; and (iv) copies of this letter may not be furnished to anyone for purposes of
encouraging such reliance. 

  
 V-8

 SCHEDULE A 

  
 A-1

 SCHEDULE VI 
 [                 ], 20[    ] 

[The Representatives] 
 as representatives of
the several Underwriters party 
 to the Underwriting Agreement 
 Ladies and Gentlemen: 
 I am the Senior Vice President and General Counsel of
General Dynamics Corporation, a Delaware corporation (the “Company”), and I have acted as legal counsel in connection with that Underwriting Agreement by and among the Company, the Guarantors named therein and [Name of
Representatives] dated [                 ], 20[    ] (the “Underwriting Agreement”). This opinion is being
delivered pursuant to Section 6(f) of the Underwriting Agreement. Initially capitalized terms not defined herein have the meanings assigned to them in the Underwriting Agreement. 

In arriving at the opinions expressed below, I am familiar with, and either I or those under my supervision have examined the following
documents, in each case including the documents incorporated by reference therein: the Registration Statement, the Time of Sale Information and the Prospectus. 
 I have also made such investigations of law, relied as to factual matters on such other documents and instruments and reviewed information or held such conferences with officers and employees of the
Company, as I have deemed appropriate. As to any fact material to my opinion, I have (with your permission and without any investigation or independent confirmation) assumed the accuracy of such instruments, certificates and documents with respect
to the facts stated therein. In rendering the opinion that follows, I have assumed and not verified (i) the genuineness of the signatures of persons signing all documents and instruments in connection with which this opinion is rendered other
than on behalf of the Company and the Guarantors, (ii) the authority of such persons signing all documents on behalf of the parties thereto other than the Company and the Guarantors, (iii) the authenticity of all documents submitted to us
as originals, (iv) the conformity to the original documents of all documents submitted to us as copies, (v) that all documents which must be executed and delivered by parties other than the Company and the Guarantors to be effective have
been duly authorized, executed and delivered by such other parties and (vi) that the Notes have been fully paid for. 
 In
clauses 1, 3 and 4 below, I have relied exclusively upon certificates or other documents from public officials as to the matters stated in such documents and certificates and such opinion is not intended to provide any conclusion or assurance beyond
that conveyed by such document or certificate. 

  
 VI-1

 Based on the foregoing and subject to the assumptions, qualifications and limitations as may
be set forth below, it is my opinion that: 
 1. each of the Guarantors has been duly incorporated and is validly existing and
in good standing under the laws of its jurisdiction of incorporation; 
 2. all of the issued shares of capital stock of each
Guarantor have been duly and validly authorized and issued, are fully paid and non-assessable and (except for directors’ qualifying shares) are owned directly or indirectly by the Company, free and clear of all encumbrances, equities or claims;

 3. the Company has been duly qualified as a foreign corporation for the transaction of business and is in good standing under
the laws of each jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except where the failure to be so qualified would not result in a material adverse change in the condition (financial
or otherwise), financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise; 
 4. each of the Guarantors has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each jurisdiction in which it owns or leases properties
or conducts any business so as to require such qualification, except where the failure to be so qualified would not result in a material adverse change in the condition (financial or otherwise), financial position or results of operations of the
applicable Guarantor; and 
 5. to the best of my knowledge after reasonable investigation, neither the Company nor any
Guarantor is (a) in violation of its Certificate of Incorporation or By-laws, as amended, or (b) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any material indenture, mortgage,
deed of trust, loan agreement, or lease or agreement or other material instrument to which it is a party or by which it or any of its properties may be bound, where such default is reasonably expected by the Company to have a material adverse change
in the condition (financial or otherwise), financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, considered as one enterprise. 

Although I have not independently verified and am not passing upon and do not assume any responsibility for the accuracy, completeness or
fairness of the statements contained in the Registration Statement, the Time of Sale Information and the Prospectus, no information has come to my attention that leads me to 

  
 VI-2

 
believe that (i) the Registration Statement, as of the Effective Time, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) the Time of Sale Information, at the Time of Sale, contained an untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, or (iii) the Prospectus, as of its date, or as of the date of this letter, contained or contains an untrue statement of a material fact or omitted or omits to
state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except for, in each case, financial statements and schedules and other financial and statistical and
similar data and information included therein or incorporated by reference therein or omitted therefrom, as to which I express no opinion. 
 I am a member of the Bar of the State of Illinois and am qualified as Corporate Counsel Registrant in the State of Virginia. This opinion is limited to the Delaware General Corporation Law, the internal
law of the State of Illinois and the federal securities laws of the United States, and I express no opinion as to the laws of any other jurisdiction. I know that the Underwriting Agreement is stated to be governed by the laws of the State of New
York. However, for purposes of rendering the opinion, I have assumed, with your permission, that the Underwriting Agreement is stated to be governed by the laws of the State of Illinois. My opinions are limited to the specific issues addressed and
are limited in all respects to laws and facts existing on the date hereof. By rendering my opinions, I do not undertake to advise you of any changes in such laws, or facts that may occur after the date hereof. 

This opinion is furnished only for your benefit and may not be relied upon by any other person or entity, nor may copies be delivered or
disclosed to any other person or entity, without my prior written consent. 
  

	
	Very truly yours,
	
	 
	Gregory S. Gallopoulos
	Senior Vice President and General Counsel

  
 VI-3

 SCHEDULE VII 
 Issuer Free Writing Prospectus 
 (relating to Preliminary Prospectus
Supplement dated 
 July 5, 2011 and Prospectus dated December 8, 2008) 

Filed pursuant to Rule 433 
 Registration Number 333-155980 
 General Dynamics Corporation

 Pricing Term Sheet 
 July 5, 2011 
 $500,000,000 1.375% Notes due 2015 

$500,000,000 2.250% Notes due 2016 
 $500,000,000 3.875% Notes due 2021 
  

			
	 Issuer:
	  	General Dynamics Corporation
		
	 Guarantors:
	  	American Overseas Marine Corporation; Bath Iron Works Corporation; Electric Boat Corporation; General Dynamics Armament and Technical Products, Inc.; General Dynamics Government
Systems Corporation; General Dynamics Land Systems Inc.; General Dynamics Ordnance and Tactical Systems, Inc.; Gulfstream Aerospace Corporation; and National Steel and Shipbuilding Company
		
	 Security Type:
	  	Senior Unsecured Notes
		
	 Securities:
	  	 1.375% Notes due 2015 (the “2015 Notes”)
 2.250% Notes due 2016 (the “2016 Notes”)
 3.875% Notes due 2021 (the “2021
Notes”)

		
	 Principal Amount:
	  	 2015 Notes: $500,000,000

2016 Notes: $500,000,000
 2021 Notes:
$500,000,000

		
	 Maturity:
	  	 2015 Notes: January 15, 2015

2016 Notes: July 15, 2016
 2021 Notes: July 15,
2021

		
	 Coupon:
	  	 2015 Notes: 1.375%
 2016
Notes: 2.250%
 2021 Notes: 3.875%

		
	 Price to Public:
	  	 2015 Notes: 99.840%
 2016
Notes: 99.877%
 2021 Notes: 99.835%

		
	 Use of Proceeds
	  	To repay $750 million principal amount of our 1.800% Notes due July 15, 2011 upon maturity and for general corporate
purposes.

  
 VII-1

			
		
	 Yield to Maturity:
	  	 2015 Notes: 1.422%
 2016
Notes: 2.276%
 2021 Notes: 3.895%

		
	 Spread to Benchmark Treasury:
	  	 2015 Notes: +68 bps
 2016
Notes: +60 bps
 2021 Notes: +78 bps

		
	 Benchmark Treasury:
	  	 2015 Notes: 0.750% due June 15, 2014
 2016 Notes: 1.500% due June 30, 2016
 2021 Notes: 3.125% due May 15, 2021

		
	 Benchmark Treasury Price / Yield:
	  	 2015 Notes: 100-00  3/4/ 0.742%
 2016 Notes: 99-05  1/4/ 1.676%

2021 Notes: 100-02+ / 3.115%

		
	 Interest Payment Dates:
	  	January 15 and July 15, commencing January 15, 2012
		
	 Make-Whole Call:
	  	 2015 Notes: 12.5 bps
 2016
Notes: 12.5 bps
 2021 Notes: 15 bps

		
	 Par Call:
	  	2021 Notes: On or after April 15, 2021 (three months prior to the maturity date)
		
	 Trade Date:
	  	July 5, 2011
		
	 Expected Settlement Date:
	  	July 12, 2011 (T+5*)
		
	 Denominations:
	  	$2,000 x $1,000
		
	 CUSIP / ISIN:
	  	 2015 Notes: 369550 AS7 / US369550AS76
 2016 Notes: 369550 AQ1 / US369550AQ11
 2021 Notes: 369550 AR9 / US369550AR93

		
	 Joint Book-Running Managers:
	  	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
 J.P. Morgan Securities LLC
 RBS Securities Inc.

Wells Fargo Securities, LLC
 Banco Bilbao Vizcaya
Argentaria, S.A.

		
	 Co-Managers:
	  	 Goldman, Sachs and Co.

Lazard Capital Markets LLC
 Lloyds Securities
Inc.
 Mitsubishi UFJ Securities (USA), Inc.
 Mizuho Securities USA Inc.
 U.S. Bancorp Investments, Inc.

ANZ Securities, Inc.
 Barclays Capital
Inc.
 BNY Mellon Capital Markets, LLC

  
 VII-2

			
		  	 Cowen and Company, LLC
 PNC
Capital Markets LLC
 SMBC Nikko Capital Markets Limited
 SunTrust Robinson Humphrey, Inc.
 TD Securities (USA) LLC

The Williams Capital Group, L.P.
 Scotia Capital
(USA) Inc.

 * T+5 Settlement. Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary
market are required to settle in three business days (such settlement being referred to as “T+3”), unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade these securities on the date of
this issuer free writing prospectus or the next succeeding business day will be required, by virtue of the fact that these securities initially will settle in T+5, to specify an alternate settlement arrangement at the time of any such trade to
prevent a failed settlement. Purchasers of these securities who wish to trade these securities on the date of this issuer free writing prospectus or the next succeeding business day should consult their advisors. 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you
invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on
the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling, Merrill Lynch, Pierce, Fenner & Smith Incorporated
toll free at 1-800-294-1322, J.P. Morgan Securities LLC collect at 212-834-4533, RBS Securities Inc. toll free at 1-866-884-2071 or Wells Fargo Securities, LLC toll free at 1-800-326-5897. 

This pricing term sheet supplements the preliminary form of prospectus supplement issued by General Dynamics Corporation on July 5, 2011 relating
to their Prospectus dated December 8, 2008. 

  
 VII-3

 SCHEDULE VIII 
 European Economic Area 
 In relation to each member state of the
European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), each underwriter has represented and agreed that with effect from and including the date on which the Prospectus Directive is
implemented in that Relevant Member State (the “Relevant Implementation Date”) it has not made and will not make an offer of notes which are the subject of the offering contemplated by this prospectus supplement to the public in that
Relevant Member State other than: 
 (a) to any legal entity which is a qualified investor as defined in the Prospectus
Directive; 
 (b) to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD
Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives for any such offer;
or 
 (c) in any other circumstances falling within Article 3(2) of the Prospectus Directive, 

provided that no such offer of notes shall require us or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive.

 For the purposes of this provision, the expression an offer of notes to the public in relation to any notes in any Relevant Member State
means the communication in any form and by any means of sufficient information on the terms of the offer and the notes to be offered so as to enable an investor to decide to purchase or subscribe for the notes, as the same may be varied in that
Member State by any measure implementing the Prospectus Directive in that Member State, the expression Prospectus Directive means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in
the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression 2010 PD Amending Directive means Directive 2010/73/EU. 
 United Kingdom 
 Each underwriter has represented and agreed that:

  
 VIII-1

 (a) it has only communicated or caused to be communicated and will only communicate or cause
to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of the notes in circumstances in which Section 21(1) of the
FSMA does not apply to us or the Guarantors; and 
 (b) it has complied and will comply with all applicable provisions of the
FSMA with respect to anything done by it in relation to the notes in, from or otherwise involving the United Kingdom. 

  
 VIII-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]